lysine has been researched along with Benign Neoplasms in 325 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (12.31) | 18.7374 |
1990's | 4 (1.23) | 18.2507 |
2000's | 49 (15.08) | 29.6817 |
2010's | 143 (44.00) | 24.3611 |
2020's | 89 (27.38) | 2.80 |
Authors | Studies |
---|---|
Jung, M; Staudt, M | 1 |
Bachmann, M; Brandt, F; Kopka, K; Laube, M; Löser, R; Pietzsch, HJ; Pietzsch, J; Ullrich, M; van den Hoff, J; Wodtke, R | 1 |
Chen, ES; Lam, UTF | 1 |
Jeon, HY; Pornour, M; Qi, J; Ryu, H | 1 |
Geng, Y; Niu, JQ; Song, TQ; Wang, YF; Yang, G; Yuan, HF; Yuan, Y; Yun, HL; Zhang, XD; Zhao, LN; Zhao, M; Zheng, W | 1 |
Abbasi, Y; Anbiyaee, O; Farzaneh, M; Ghaedrahmati, F; Gholami, E; Kuchaki, Z; Meybodi, SM; Rashid Sheykhahmad, F | 1 |
Barceló, C; Javed, A; Malagraba, G; Rubio-Tomás, T; Yarmohammadi, M | 1 |
Burchell, JM; Taylor-Papadimitriou, J | 1 |
Kong, F; Ma, L; Tang, R; Wang, X; You, H; Zheng, K | 1 |
Gu, MZ; Han, C; Li, ZR; Xu, X; Zhang, HL; Zhang, JH | 1 |
Li, X; Nie, S; Song, Y; Wu, F; Wu, J; Yao, Y; Zhou, C | 1 |
Ding, P; Feng, Y; Han, J; Jiang, M; Li, H; Liu, D; Lu, D; Ma, Z; Pan, M; Shao, C; Wang, J; Yan, X; Zhang, Y | 1 |
Contreras, J; El-Sherif, AA; Froux, A; Martín-Hurtado, A; Mohamed, HT; Plaza-Menacho, I; Shehata, MA | 1 |
Biggar, KK; Chopra, A; Willmore, WG | 1 |
Chen, Y; Ma, L; Sun, Y; Yao, F; Yao, Y; Zhou, D | 1 |
Barghout, SH; Barsyte-Lovejoy, D; Machado, RAC | 1 |
Chen, M; Chen, X; Guo, Z; Liang, R; Tian, H; Wang, Z | 1 |
Diao, W; Li, Y; Wang, J; Xu, S; Zheng, J | 1 |
Castiello, C; Fiorentino, F; Mai, A; Rotili, D | 1 |
Abu-Hanna, J; Anastasakis, E; Clapp, LH; Cohen, R; Eddama, MMR; Loizidou, M; Patel, JA | 1 |
Bouleau, A; Chevaleyre, C; Dubois, S; Evans, MJ; Kereselidze, D; Kuhnast, B; Nozach, H; Richard, M; Specklin, S; Tran, VL; Truillet, C | 1 |
Ding, L; Li, Y; Rao, GW; Ren, S; Zhang, W | 1 |
Li, WH; Li, YM; Su, JY | 1 |
Ambrosi, C; Baubec, T; Faller, WJ; Haarhuis, JHI; Kwesi-Maliepaard, EM; Liu, NQ; Malik, M; Molenaar, TM; Silva, J; van Leeuwen, F; van Welsem, T | 1 |
Bartling, CRO; Bolding, JE; Davies, MJ; Gamon, LF; Hansen, TN; Martín-Gago, P; Olsen, CA; Rajabi, N; Strømgaard, K | 1 |
De Martino, M; Vanpouille-Box, C | 1 |
Azagra, A; Cobaleda, C | 1 |
Cang, W; Chen, L; Gu, Y; Huang, L; Sun, P; Xiang, Y | 1 |
Kundu, TK; Senapati, P; Singh, S | 1 |
Abousaida, B; Carter, R; Derry, P; Gonzalez, VV; Kim, JBK; Krishnan, S; Liopo, AV; Mackeyev, Y; Rauta, PR; Sanders, K; Shohayeb, MA; Singh, P; Tezcan, O; Vijay, GV; Zahra, Y; Zubarev, ER | 1 |
Cheng, Y; Deng, X; Jia, L; Li, S; Lian, S; Lu, Y; Wang, J; Zhai, S | 1 |
Han, D; Lu, K | 1 |
Mohri, K; Mukai, H; Nhat, KPH; Tagami, S; Wada, Y; Warashina, S; Watanabe, Y; Zouda, M | 1 |
Chen, S; Cheng, K; Debnath, B; Han, H; Liang, B; Liu, Y; Lombard, DB; Neamati, N; Shu, K; Wang, Q; Wu, M; Yao, J; Yin, Y; Zheng, Y | 1 |
Ranathunga, DTS; Torabifard, H | 1 |
Mao, L; Wang, J; Wang, JH; Wen, Q; Wu, M; Yu, SC; Zhang, X | 1 |
Chen, J; Chen, LJ; Li, CY; Liu, YJ; She, QS; Tao, F; Xu, XY; Yang, GJ; Zhong, XD; Zhu, MH | 1 |
Chen, Y; Li, Z; Lin, C; Wang, G; Zhang, L; Zhang, T | 1 |
Brown, MA; Crans, DC; Huesgen, L; Manganaro, JF; Padilla, A; Roess, DA | 1 |
Agnew, DW; Bachmann, AS; Demireva, EY; Geerts, D; Schultz, CR; Sheldon, RD; Uhl, KL; Xie, H | 1 |
Cheng, C; Deng, CM; He, Y; Li, A; Li, B; Li, SJ; Li, ZG; Liang, YY; Liao, L; Liu, JB; Liu, ZC; Wei, X; Xu, TY; Yang, H; Yang, J; Yu, XM; Zhang, GG; Zheng, CC; Zhu, YD | 1 |
Leung, CH; Ma, DL; Song, YQ; Wang, W; Yang, GJ | 1 |
Cai, NL; Lau, ATY; Wu, GQ; Wu, YY; Xu, YM | 1 |
Bashtrykov, P; Bröhm, A; Bui, T; Jeltsch, A; Khella, MS; Pleiss, J; Schnee, P; Weirich, S | 1 |
Abdullah, KG; Chatoff, A; Duan, T; Gao, J; Huang, T; Jin, C; Megill, E; Rich, JN; Snyder, NW; Wang, S; Wu, Q; Wu, X; Yang, K; Yuan, F; Yuan, H; Zhao, L; Zhao, Y; Zinn, PO | 1 |
Ardana, A; Fletcher, NL; Ghosh, S; Huda, P; Thurecht, KJ; Williams, CC | 1 |
Locasale, JW; Wei, F | 1 |
Ko, CN; Li, D; Tian, T; Yang, C | 1 |
Bao, L; Mou, Y; Qin, Y; Song, Y; Zhu, P | 1 |
Abini-Agbomson, S; Armache, KJ; Burg, JM; Cheek, MA; De Ioannes, P; Ezell, RJ; Gloor, SL; Godínez-López, V; Gopinath, S; Gretarsson, K; Hickman, AR; Keogh, MC; Lee, R; Lu, C; Meiners, MJ; Nudler, E; Pasini, D; Rice, WJ; Rustichelli, S; Sun, L; Sun, ZW; Svetlov, V; Tamburri, S; Taylor, HF; Thomas, JF; Vaidya, A; Valencia-Sánchez, MI | 1 |
Jadhav, HR; Jain, P; Manchanda, N; Wahi, A | 1 |
Ju, Y; Li, Z; Pang, X; Ren, L; Sun, X; Wang, W; Wu, Z; Zhang, J; Zhang, Y; Zhao, Y; Zhao, Z; Zhou, Y | 1 |
Prasad, SK; Sindhu, R; Supreeth, M; Thanmaya, M | 1 |
Mao, F; Shi, YG | 1 |
Chen, Y; Hu, J; Huang, C; Li, K; Li, X; Liu, A; Liu, L; Qiu, C; She, X; Song, D; Wan, K; Wang, G; Wang, J; Wu, Q; Xu, F; Yu, C | 1 |
Eccleston, M; Herzog, M; Kotronoulas, A; Lobbens, A; Pamart, D; Rommelaere, G; Van den Ackerveken, P | 1 |
Afenjar, A; Banka, S; Barish, S; Bellen, HJ; Blyth, M; Choufani, S; Costain, G; Cytrynbaum, C; Deshwar, AR; Haldeman-Englert, C; Hayes, I; Haynes, D; Huang, Y; Jobling, R; Kanca, O; Keren, B; Le Quesne Stabej, P; Mao, X; Mignot, C; Nil, Z; Prescott, T; Robin-Renaldo, F; Shinawi, M; Sisco, K; Tveten, K; Vøllo, A; Wangler, MF; Wegner, DJ; Weksberg, R; Wheeler, PG; Wilson, C; Yamamoto, S; Yap, P; Zhang, X; Zon, J | 1 |
Chandnani, N; Gupta, I; Sarkar, K; Thakkar, V | 1 |
Deng, J; Liao, X | 1 |
Barroso-González, J; Bernstein, KA; de Vitis, M; García-Expósito, L; Ghosh, A; Hoang, SM; Lynskey, ML; Modesti, M; O'Sullivan, RJ; Roncaioli, JL; Sarkar, SN; Wallace, CT; Watkins, SC | 1 |
Cornett, EM; Defossez, PA; Ferry, L; Rothbart, SB | 1 |
Mi, YY; Song, NH; Wang, ZJ; Yuan, W; Zhang, LF; Zhang, W; Zhu, LJ; Zuo, L | 1 |
Chandra, D; Gogada, R; Gundampati, RK; Hashmi, S; Jayanthi, S; Kumar, R; Lella, R; O'Malley, J; Suresh Kumar, TK; Wang, J; Yadav, N; Zhang, D | 1 |
Adams, S; Archer, KE; Bai, C; Chari, R; Harvey, L; Keating, TA; Kovtun, Y; Laleau, R; Maloney, EK; Miller, ML; Reid, EE; Shizuka, M; Vitharana, D; Wilhelm, A; Yoder, NC | 1 |
Chakraborty, D; Clarke, TL; Ji, F; Jin, J; Kaniskan, HÜ; Lawrence, MS; Ma, A; Mishra, S; Sadreyev, RI; Tang, R; Van Rechem, C; Whetstine, JR | 1 |
Casanova, AG; Chuffart, F; Lukinović, V; Reynoird, N; Roth, GS | 1 |
Gao, J; Gao, Y; Guo, L; Zhang, Y; Zhu, Z | 1 |
Chen, J; Huang, K; Li, J; Li, R; Sun, R; Wang, Y; Xie, K; Yang, Q; Zhang, T; Zhang, Y; Zhao, Q; Zou, L | 1 |
Butcher, D; Karim, B; Kobayashi, H; Liu, XF; Molitoris, BA; Nagaya, T; Okada, R; Pastan, I; Sandoval, R; Wei, J; Zhou, Q | 1 |
Chen, R; Dou, J; Huang, J; Shu, Z; Wang, Y; Yu, J; Yuan, H; Zhang, H; Zhao, X; Zhou, A | 1 |
Kosciuk, T; Lin, H | 1 |
Cheng, L; Li, L; Liang, Y; Liu, M; Wang, R; Xia, J; Yue, L; Zhang, L; Zhang, N | 1 |
Dent, SYR; Farria, AT; Koutelou, E | 1 |
Cheng, H; Deng, W; Guo, Y; Jiang, P; Ning, W; Xu, H; Xue, Y | 1 |
Huttner, D; Meller, A; Ohayon, S; Zrehen, A | 1 |
Cheng, H; Du, Y; Gao, X; Li, X; Liu, Z; Liu, ZX; Yu, K; Zhang, Q; Zhao, Q | 1 |
Bernard, BJ; Burkitt, K; Nakamura, Y; Nigam, N; Saloura, V; Vougiouklakis, T | 1 |
Klonou, A; Markouli, M; Papavassiliou, AG; Piperi, C; Strepkos, D | 1 |
Coller, HA; Corvalan, AZ | 1 |
Hu, J; Li, S; Xia, X; Zhao, Q | 1 |
Ahmed, Z; Bacolla, A; Cooper, DN; De-Paula, RB; Hegde, ML; Mitra, J; Mitra, S; Mort, M; Sengupta, S; Tainer, JA; Yang, C; Ye, Z | 1 |
Gu, W; Kon, N; Li, H; Ou, Y; Rustgi, AK; Wang, SJ | 1 |
Barshop, W; Bradley, LM; Finlay, D; Garcia, G; Gimple, RC; Hope, JL; Qiu, Z; Rantala, J; Rich, JN; Sangfelt, O; Shen, JZ; Spruck, C; Sun, D; Wohlschlegel, J; Wu, Q | 1 |
Breau, RH; Cagiannos, I; Fergusson, DA; Flaman, A; Hutton, B; Lavallée, LT; Montroy, J; Morash, C; Tinmouth, A | 1 |
Akther, M; Cho, DY; Choi, DK; Haque, ME; Jakaria, M; Kim, IS | 1 |
Gong, X; Liu, F; Su, M | 1 |
Chen, R; Hou, G; Huang, C; Jiang, B; Li, L; Liu, X; Lu, R; Wang, Y; Yang, Q; Yu, J; Zhao, X | 1 |
Allis, CD; Chen, H; Chen, X; Lu, C; Majewski, J; Rajagopalan, KN; Weinberg, DN | 1 |
Bauer, D; Hauser, S; Kopka, K; Laube, M; Löser, R; Neuber, C; Pietsch, M; Pietzsch, J; Rothe, R; Wodtke, J; Wodtke, R | 1 |
Jeon, M; Kim, H; Lee, JM; Park, IG | 1 |
Allegretti, M; Bellassai, N; Corradini, R; D'Agata, R; Giacomini, P; Huskens, J; Marti, A; Rozzi, A; Spoto, G; Volpi, S | 1 |
Fujiki, K; Tanaka, K | 1 |
Breau, RH; Cagiannos, I; Cnossen, S; Fergusson, DA; Fergusson, NA; Hutton, B; Lavallée, LT; Montroy, J; Morash, C | 1 |
Dash, J; Pantoş, GD; Răsădean, DM; Sheng, B | 1 |
Zaware, N; Zhou, MM | 1 |
Ambrosio, S; Majello, B; Saccà, CD | 1 |
Chau, LY; Chiang, MT; Hsu, FF; Lee, WH; Li, FA; Yeh, CT | 1 |
Burke, KA; Conicella, AE; Fawzi, NL; Janke, AM; Mathews, KL; Mittal, J; Rahmanian, V; Seo, DH | 1 |
Chen, R; Cui, N; Deng, R; Dou, J; Huang, J; Liu, T; Wang, J; Wang, Y; Yu, J; Zhang, H; Zhao, X | 1 |
Dutra, LA; Heidenreich, D; Knapp, S; Man Chin, C; Santos, JLD; Silva, GDBD | 1 |
Carpenter, BL; Chariou, PL; Ghiladi, RA; Gulati, NM; Hu, H; Masarapu, H; Patel, BK; Shukla, S; Steinmetz, NF | 1 |
Ma, S; Zhang, F | 1 |
Guo, YR; Hawke, D; He, J; Lee, JH; Li, XJ; Liu, K; Liu, R; Lu, Z; Lyu, J; Qian, X; Tan, L; Tao, YJ; Wang, Y; Xia, Y; Xing, D; Yang, P; Yin, Z; Zheng, Y | 1 |
Chen, R; Garcia, JA; Nagati, J; Xu, M | 1 |
Alabugin, IV; Basak, A; Bhattacharya, P; Campbell, A | 1 |
Fan, YR; Huang, M; Huang, Y; Song, Y; Tian, DN; Wu, CX; Yang, XB | 1 |
Alexander, C; Almarwani, B; Nguyen, HAT; Phambu, EN; Phambu, N; Sunda-Meya, A | 1 |
Garza, N; Jin, VX; Kornblau, S; Li, T; Liu, Q | 1 |
Bondy-Chorney, E; Denoncourt, A; Downey, M; Sai, Y | 1 |
Boriack-Sjodin, PA; Chesworth, R; Copeland, RA; Duncan, KW; Harvey, DM; Janzen, WP; Kuntz, KW; Lampe, JW; Mitchell, LH; Morrison, MJ; Sadalge, D; Scott, MP; Swinger, KK; Wigle, TJ | 1 |
Dai, Z; Gao, X; Locasale, JW; Mentch, SJ; Nichenametla, SN | 1 |
Brasher, B; Fu, TM; Gan, W; Hauenstein, AV; Liang, AC; Liu, P; Schwerdtfeger, C; Su, S; Wei, W; Xu, M | 1 |
Chan, DV; Hara, E; Iimori, M; Kitao, H; Maehara, Y; Watanabe, S | 1 |
Brown, AM; Finkielstein, CV; Gotoh, T; Jiang, L; Kim, JK; Liu, J; Wisdom, EL; Zou, X | 1 |
Bai, Y; Chen, T; Guo, X; Hu, R; Hu, Z; Huang, X; Jiang, S; Liu, H; Liu, X; Meng, X; Sun, SC; Wei, L; Xu, C; Xue, M; Yang, W; Zhou, P | 1 |
Li, L; Li, R; Wang, Y | 1 |
Cui, H; Dong, Z; Lei, Q; Li, L; Li, Q; Mao, J; Yang, J; Yang, L | 1 |
Chen, L; Fang, Q; Li, W; Li, Z; Liang, W; Liu, N; Lu, F; Tian, Y; Wang, D; Xie, M; Yin, F; Zhao, H; Zhao, R | 1 |
Allis, CD; Bagert, JD; Feng, L; Gao, J; Kundra, R; Lemiesz, AE; Muir, TW; Nacev, BA; Schultz, N; Soshnev, AA | 1 |
Chen, Y; Chu, X; Han, D; Huang, M; Lei, Z; Li, Z; Liu, C; Wang, T | 1 |
Chen, D; Chen, X; Li, H; Li, K; Liang, J; Liu, Y; Xu, X; Zeng, Q; Zeng, Y; Zhan, Y | 1 |
Guo, J; Wei, W | 1 |
Chen, R; Cui, N; Dou, J; Guo, Y; Huang, J; Liu, T; Wang, Y; Yang, Q; Yu, J; Zhang, H; Zhao, X | 1 |
Chu, H; Felten, AE; Leamon, CP; Lu, YJ; Nelson, M; Parker, N; Reddy, JA; Shillingford, JM; Vaughn, JF; Vlahov, IR; Wang, EZ; Westrick, E; Xu, LC | 1 |
Bros, C; Chan, PK; Kalkat, M; Kim, SS; Konforte, D; Oliveri, S; Pandyra, A; Penn, LZ; Raught, B; Sedivy, E; Wasylishen, AR | 1 |
Li, Y; Liu, C; Xu, W; Zhao, S | 1 |
Allen, JR; Chen, CY; Johnson, DL; Rohira, AD | 1 |
Arinbasarova, AY; Berezov, TT; Lukasheva, EV; Medentzev, AG; Pokrovsky, VS; Sedakova, LA; Treshalina, HM | 1 |
Babinski, DJ; Best, AM; Brekken, RA; Bruick, R; Chang, J; Dellinger, M; Easmon, J; Frantz, DE; Kumar, S; Martinez, ED; Peña-Llopis, S; Quinn, AM; Ruiz, J; Simeonov, A; Varghese, D; Wang, L; Xu, J | 1 |
Gao, FY; Shen, JM; Tian, XZ; Xu, S; Yin, T | 1 |
Guan, KL; Huang, W; Lei, QY; Lin, R; Lv, L; Xiong, Y; Zhao, D; Zhou, X | 1 |
Chandrasekharan, P; Chuang, KH; He, T; Poh, Z; Raju, A; Robins, EG; Yang, CT | 1 |
Li, GM | 1 |
Chitalia, V; Costello, CE; Hartsough, EJ; Jiang, Y; Marquez, VE; Meyer, RD; Rahimi, N; Weinberg, J; Zhdanova, IV | 1 |
Gu, Z; Jiang, W; Lai, K; Wu, Y | 1 |
Díaz-Tejada, C; Grande-García, A; Lallous, N; Ramón-Maiques, S | 1 |
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Chun, YS; Park, JW; Shin, DH; Shin, SH; Yoon, H | 1 |
Aguiar, M; Alečković, M; Arellano, M; Boggon, TJ; Britton, LM; Chen, H; Chen, J; Devi, N; Elf, S; Fan, J; Gaddh, M; Garcia, BA; Gu, TL; Hitosugi, T; Kaluz, S; Kang, HB; Kang, S; Kang, Y; Khoury, HJ; Khuri, FR; Lonial, S; Lonning, S; Mohammadi, M; Seo, JH; Shan, C; Tucker, M; Van Meir, EG; Xie, J | 1 |
D'Argenio, V; Esposito, MV; Frisso, G; Gilder, JA; Salvatore, F | 1 |
Choi, M; Kim, JE; Kim, W | 1 |
Meslamani, J; Sanchez, R; Zhou, MM | 1 |
Van Rechem, C; Whetstine, JR | 1 |
Bailey, KM; Balagurunathan, Y; Cornnell, HH; Gillies, RJ; Hashim, AI; Ribeiro, MC; Wojtkowiak, JW | 1 |
Chen, G; Jiao, H; Li, J; Mei, Z; Wang, W; Xu, Y | 1 |
Chen, CY; Chen, HY; Chen, KB; Chen, KC | 1 |
Bauer, A; Gerrits, B; Hoving, S; Kirschner, MW; Luchansky, SJ; Nagel, J; Schirle, M; Thomas, JR; Thompson, JW | 1 |
Buettner, GR; Gius, D; Jung, B; Ozden, O; Park, SH; Song, HY; Vassilopoulos, A; Wagner, BA; Zhu, Y | 1 |
Alfarano, MG; Jayaraman, P; Kidwai, S; Lu, G; Parikh, F; Sikora, AG; Svider, PF; Xiong, H | 1 |
Barbacid, M; Beijersbergen, RL; Bernards, R; Drosten, M; García-Medina, R; Huang, S; Jacob, HK; Lechuga, CG; Simón-Carrasco, L; Sum, EY | 1 |
Gao, C; Huang, F; Mao, Z; Yu, G; Yu, W | 1 |
Fukami, K; Matsui, T; Yamagishi, S | 1 |
Benes, CH; Black, JC; Burrowes, PD; Christiani, DC; Donado, C; Greninger, P; Ladd, B; Van Rechem, C; Whetstine, JR; Zhao, Y | 1 |
McGrath, J; Trojer, P | 1 |
Dent, SY; Farria, A; Li, W | 1 |
Dasgupta, M; Dermawan, JK; Stark, GR; Willard, B | 1 |
Dunne, K; Flashman, E; Hancock, RL; Kawamura, A; Walport, LJ | 1 |
Cal, PM; Cordeiro, C; Frade, RF; Gois, PM | 1 |
Hershey, JW; Mathews, MB | 1 |
Balabanov, S; Bokemeyer, C; Braig, M; Hagel, C; Haralambieva, E; Hauber, J; Hermans-Borgmeyer, I; Nagel, CH; Neumann, M; Pällmann, N; Preukschas, M; Schweizer, M; Sievert, H; Wild, P | 1 |
Ashkenazi, A; Chen, TT; Filvaroff, E; Jubb, A; Koeppen, H; Marsters, S; Merchant, M; Peng, J | 1 |
Burchfield, JS; Li, Q; Wang, HY; Wang, RF | 1 |
Chen, C; Chen, Q; Chen, R; Deng, R; Dou, J; Huang, J; Jin, H; Wang, Y; Xu, M; Yu, J; Zhang, H; Zhao, X; Zhu, C | 1 |
Barsotti, AM; Rollins, RA; Ryskin, M | 1 |
Ariyan, CE; Berger, MF; Borsu, L; Busam, KJ; Button, J; Cao, Z; Chen, Y; Chi, P; Fagin, JA; Gao, D; Hollmann, TJ; Hu, W; Ladanyi, M; Lailler, N; Landa, I; Lee, W; Merghoub, T; Murali, R; Murphy, DA; Obenauf, AC; Postow, MA; Ran, L; Sboner, A; Schwartz, GK; Scott, SN; Shah, RH; Shukla, S; Wang, L; Wiesner, T; Wong, EW; Zhang, QF; Zheng, D | 1 |
Delgado-Andrade, C | 1 |
Chen, H; Jiang, C; Li, X; Li, Y; Pan, T; Wang, Z; Xu, J; Zhang, J; Zhao, Z | 1 |
D'Angiolella, V; Dianov, GL; Drobnitzky, N; Humphrey, TC; Jiang, Y; La Thangue, NB; Macaulay, VM; Markkanen, E; Mavrommati, I; Orlando, G; Pai, CC; Pfister, SX; Ryan, AJ; Sarkar, S; Verrill, C; Woodcock, M; Ying, S; Zalmas, LP | 1 |
Kaypee, S; Kundu, TK; Mukherjee, D; Sethi, G; Shanmugam, MK; Sudarshan, D | 1 |
Chen, Y; Hu, B; Ji, W; Liu, X; Mei, Z; Ouyang, G; Wang, J; Xiao, W; Zhang, D; Zhang, W; Zhou, C; Zhou, J | 1 |
Aires, D; Axiak-Bechtel, SM; Bryan, JN; Cai, S; Douglas, J; Forrest, ML; Forrest, WC; Groer, C; Mohr, E; Selting, KA; Swarz, JA; Tate, DJ; Yang, Q; Zhang, T | 1 |
Baba, T; Chiba, T; Ebina, M; Endo, T; Fukuda, T; Haratake, K; Kanemori, Y; Kigoshi, Y; Kim, J; Miyahara, H; Takebe, A; Tsuruta, F | 1 |
Leng, Q; Mixson, AJ | 1 |
Del Bufalo, D; Di Martile, M; Trisciuoglio, D | 1 |
Cleveland, JL; Nakanishi, S | 1 |
Kanoh, D; Kikuchi, S; Nakamura, H; Sakurai, Y; Sato, S; Suzuki, M | 1 |
Liu, HM; Liu, Y; Ma, JL; Zheng, YC | 1 |
Bizet, M; Brenner, C; Calonne, E; Cartron, PF; Dedeurwaerder, S; Defrance, M; Deplus, R; Fuks, F; Josseaux, E; Luciani, J; Ndlovu, M; Putmans, P | 1 |
Dupéré-Richer, D; Ezponda, T; Licht, JD; Miller, WH; Nichol, JN | 1 |
Alabugin, IV; Kaya, K; Nogues, JC; Rojas, JC; Roy, S; Sokolikj, Z; Zorio, DA | 1 |
Giaccia, AJ | 1 |
Carlson, SM; Gozani, O | 1 |
Dohmae, N; Hamamoto, R; Matsuo, Y; Nakakido, M; Nakamura, Y; Simone, C; Suzuki, T; Tsurita, G; Watanabe, T; Yoshioka, Y | 1 |
Encarnación-Guevara, S; Gil, J; Ramírez-Torres, A | 1 |
Taniguchi, Y | 1 |
Jiang, L; Mao, H; Wang, Y; Xue, Z; Zhu, D | 1 |
Esteller, M; Pérez-Salvia, M | 1 |
Bazarov, N; Celik, A; Cigdem, S; Gunduz, E; Kahraman, B; Kaya, T; Toker, AS | 1 |
Filippakopoulos, P; Fujisawa, T | 1 |
Dwane, L; Gallagher, WM; Ní Chonghaile, T; O'Connor, DP | 1 |
Chakravarti, D; Chen, JR; Chen, P; Deng, P; DePinho, RA; Dey, P; Lan, Z; Li, J; Liang, X; Liao, W; Lu, X; Navone, NM; Shah, S; Shang, X; Spring, DJ; Tang, M; Troncoso, P; Wang, G; Wang, YA; Zhang, J; Zhao, D | 1 |
Anselmi, F; Basile, G; Incarnato, D; Krepelova, A; Maldotti, M; Neri, F; Oliviero, S; Parlato, C; Rapelli, S | 1 |
Basu, M; Chakrabarti, P; Das, C; Khan, MW | 1 |
Champagne, KS; Gozani, O; Hom, RA; Hung, T; Kuo, AJ; Kutateladze, TG; Li, G; Lin, H; Peña, PV; Subach, OM; Verkhusha, VV; Wong, RP; Zhao, R | 1 |
Klose, RJ; Ng, SS; Oppermann, U; Yue, WW | 1 |
Falke, JJ; Landgraf, KE; Pilling, C | 1 |
Ateeq, B; Brenner, JC; Cao, Q; Cao, X; Chinnaiyan, AM; Han, B; Jing, X; Kim, JH; Kumar-Sinha, C; Laxman, B; Lonigro, RJ; Maher, CA; Mani, RS; Palanisamy, N; Ramnarayanan, K; Shankar, S; Tan, P; Varambally, S; Wang, X; Yu, J | 1 |
Fujisaki, Y; Horii, Y; Nagai, K; Shen, J | 1 |
Hu, L; Qi, C; Zhu, YJ; Zhu, YT | 1 |
La Thangue, NB; Stimson, L | 1 |
Allis, CD; Cook, RG; Frierson, HF; Fujita, M; Fukusato, T; Iizuka, M; Mizzen, CA; Smith, MM; Takahashi, Y | 1 |
Bode, AM; Cho, YY; Dong, Z; Malakhova, ML; Pugliese, A; Yao, K | 1 |
Clerkin, K; Liang, JF; Shah, K; Tu, Z; Volk, M | 1 |
Alabugin, IV; Ben, C; Breiner, B; Copland, JA; Kovalenko, SV; LeGrand, SN; Sang, QX; Singh, M; Strouse, GF; Yang, WY | 1 |
Abraham, RT; Aslanian, A; Brognard, J; Coughlin, C; Dolled-Filhart, M; Hunter, T; Manning, G; You, Z; Zhang, YW | 1 |
Hauser, AT; Heinke, R; Jung, M; Sippl, W; Spannhoff, A | 1 |
Dubrot, J; Martinez-Forero, I; Melero, I; Palazon, A; Rouzaut, A | 1 |
Bazan, F; Dixit, VM; Dornan, D; Eastham-Anderson, J; Ferrando, R; French, DM; Huang, DC; Huang, X; Lill, JR; Liu, J; Maecker, H; O'Rourke, K; Schwickart, M; Yue, P | 1 |
Alekseev, SB; Shevchenko, AA; Smirnova, IP | 1 |
Berger, SL; Chuikov, S; Dorsey, J; Huang, J; Jenuwein, T; Reinberg, D; Zhang, X | 1 |
Füllgrabe, J; Hajji, N; Hermanson, O; Joseph, B; Vlachos, P; Wallenborg, K | 1 |
Bergmann, A; Bolduc, C; Buff, E; Chen, Z; Davuluri, R; Gupta, R; Hariharan, IK; Herz, HM; Madden, LD; Shilatifard, A | 1 |
Lin, HK; Yang, WL; Zhang, X | 1 |
Akbarian, S; Hock, H; Huang, HS; Mostoslavsky, R; Qin, J; Van Buren, D; Zhong, L | 1 |
Baek, SH; Binda, O; Choi, HJ; Gozani, O; Hwang, D; Kim, B; Kim, IS; Kim, JH; Kim, JY; Kim, KI; Kim, M; Kim, Y; Lee, H; Lee, JM; Lee, JS; Semenza, GL; Seo, SB; Shin, HJ | 1 |
Kalinovsky, T; Monterrey, JC; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Abbasi, M; Berthiaume, LG; Lavasanifar, A; Uludağ, H; Weinfeld, M | 1 |
Chen, HW; Gemo, AT; Kalashnikova, EV; Revenko, AS; Zou, JX | 1 |
Allis, CD; Duncan, EM | 1 |
Lu, T; Stark, GR; Wang, Y | 1 |
Hübner, MR; Spector, DL | 1 |
Ahn, WS; Baek, KH; Lee, EJ; Lee, HJ; Ramakrishna, S; Suresh, B | 1 |
Boyd, BJ; Kaminskas, LM; Kelly, BD; McLeod, VM; Owen, DJ; Porter, CJ; Sberna, G | 1 |
Aldawsari, H; Blatchford, DR; Dufès, C; Edrada-Ebel, R; Raj, BS; Tate, RJ; Tetley, L | 1 |
Aldawsari, H; Blatchford, DR; Dufès, C; Edrada-Ebel, R; Tate, RJ; Tetley, L | 1 |
Abbasi, M; Aliabadi, HM; Doillon, C; Kaur, K; Lai, R; Lavasanifar, A; Moase, EH; Uludağ, H | 1 |
Jaramillo-Lambert, AN; Lee, NH; Li, Y; Williams, R; Yang, Y; Zhu, W | 1 |
Dwarakanath, BS; Ganguli, M; Jiang, Y; Kalra, N; Khanduri, R; Langel, U; Mann, A; Naik, R; Shukla, V; Singh, AK; Thakur, G | 1 |
Wolf, DH | 1 |
Peng, L; Seto, E | 1 |
Atadja, P; Dai, J; Gu, J; Li, E; Li, L; Lu, C; Luo, X; Wang, L; Zhang, H; Zhao, K; Zhou, S; Zhu, J | 1 |
Raines, RT; Sundlass, NK | 1 |
Beland, FA; Koturbash, I; Pogribny, IP; Simpson, NE | 1 |
Jang, H; Lee, SJ; Park, C | 1 |
Richon, VM | 1 |
Lee, JH; Marks, PA | 1 |
Abbruzzese, A; Caraglia, M; Marra, M; Park, MH; Wolff, EC | 1 |
Seto, E; Telles, E | 1 |
Huang, C; Li, J; Liu, J; Wu, XR; Yu, J; Yu, Y; Zhang, D | 1 |
Duan, Y; Liu, P; Sun, Y; Yu, H; Zhu, M | 1 |
Becker, A; Chandra, P; Dittrich, T; Klusmann, JH; Lippka, Y; Reinhardt, D; Selvakumar, D; Thakur, BK; Welte, K | 1 |
Decarlo, D; Hadden, MK | 1 |
Ikegami, D; Kim, YJ; Niwa, T; Takeshima, H; Ushijima, T; Wakabayashi, M | 1 |
Chen, S; Liu, Y; Sun, FL; Wang, DL; Zhao, L | 1 |
Black, JC; Whetstine, JR | 1 |
Gozani, O; Hammell, M; Joshua-Tor, L; Kuo, A; McCombie, WR; Mills, AA; Paul, S; Schalch, T; Vogel, H | 1 |
Chou, ST; Kahn, JD; Leng, Q; Mixson, AJ; Scaria, P; Tricoli, LJ; Woodle, M | 1 |
Douvlis, Z | 1 |
Hirohashi, S; Koizume, S; Sekiya, T; Shiraishi, M; Tachibana, K | 1 |
Boehncke, WH; Elliott, PJ; Zollner, TM | 1 |
GREENBERG, DM; OLSON, ME; RABINOVITZ, M | 1 |
ANDERSON, DC; BUSCH, H; DAVIS, JR | 2 |
LEACH, FR | 1 |
DAVIS, JR; MORRIS, RN | 1 |
BUSCH, H; HNILICA, LS; TAYLOR, CW | 1 |
BUSCH, H; HNILICA, LS; MAVIOGLU, H; STEELE, WJ; TAYLOR, CW | 1 |
BUSCH, H; STEELE, WJ | 1 |
GENTY, N; MELONI, GA; VENDRELY, R | 1 |
CHRISTENSEN, HN | 1 |
HOLLINSHEAD, AC | 1 |
MCQUEEN, JD; MEGO, JL | 2 |
FARAONI, H; FROMM, GA; HECKER, E; NAJENSON, H | 1 |
KRISHNA, G | 1 |
Hahm, KS; Lee, DG; Park, Y | 1 |
Aratani, Y; Furuhata, A; Kawai, Y; Toyokuni, S; Uchida, K | 1 |
Yang, XJ | 1 |
Albiez, H; Cremer, C; Cremer, M; Cremer, T; Stein, S; Wagler, B; Zinner, R | 1 |
Kentsis, A; Miller, F; Osman, R; Pan, ZQ | 1 |
Ahn, N; Ballestar, E; Boix-Chornet, M; Bonaldi, T; Calasanz, MJ; Caldas, C; Calvo, E; Cano, A; Colomer, D; Espada, J; Esteller, M; Fraga, MF; Haydon, C; Imhof, A; Iyer, NG; Jenuwein, T; Lopez, JA; Pérez-Rosado, A; Petrie, K; Piris, MA; Ropero, S; Schotta, G; Villar-Garea, A | 1 |
Hoekman, K; Niessen, HW; Schalkwijk, CG; van Heijst, JW | 1 |
Berndorff, D; Borkowski, S; Cyr, JE; Dinkelborg, LM; Friebe, M; Hilger, CS; Rother, A; Sieger, S; Viti, F | 1 |
Clement, PM; Johansson, HE; Park, MH; Wolff, EC | 1 |
Kroetz, MB | 1 |
Akimoto, N; Hashida, M; Kawakami, S; Niidome, T; Okuda, T; Yamashita, F | 1 |
Bernard, B; Bijster, M; de Jong, M; Forrer, F; Krenning, EP; Rolleman, EJ; Valkema, R; Vermeij, M | 1 |
Fischer, PM; Heery, DM | 1 |
Ben-Shushan, E; Bergman, Y; Cedar, H; Eden, E; Farkash, S; Hecht, M; Keshet, I; Reubinoff, BE; Schlesinger, Y; Simon, I; Straussman, R; Yakhini, Z; Zimmerman, J | 1 |
Ambulos, N; Cambell, P; Goldgeier, L; Leng, Q; Mixson, AJ; Zhu, J | 1 |
Eisenman, RN; Secombe, J | 1 |
Reinberg, D; Sternglanz, R; Vaquero, A | 1 |
Shi, Y | 1 |
Li, K; Teng, LJ | 1 |
Morrison, Z; Wiencke, JK; Yeh, RF; Zheng, S | 1 |
Horinouchi, S; Shimazu, T; Yoshida, M | 1 |
Ashworth, A; Barford, D; Hofmann, K; Komander, D; Lord, CJ; Scheel, H; Swift, S | 1 |
Jeong, EG; Kim, MS; Lee, SH; Yoo, NJ | 1 |
Baert, JL; de Launoit, Y; Degerny, C; Wohlkonig, A | 1 |
Ahmed, S; Boumber, Y; Haddad, BR; Issa, JP; Kondo, Y; Sekido, Y; Shen, L | 1 |
Brown, RR | 1 |
Tabor, CW; Tabor, H | 1 |
Devoghel, JC | 1 |
Szent-Györgyi, A | 1 |
Tisdale, MJ | 1 |
Brouckaert, P; Fiers, W; Takahashi, N | 1 |
Gebbink, MF; Reijerkerk, A; Voest, EE | 1 |
Allis, CD; Rice, JC | 1 |
Dyson, MH; Mahadevan, LC; Rose, S | 1 |
Ballario, P; Filetici, P; P, O | 1 |
Carrasquillo, JA; Jeong, HJ; Kao, CH; Kim, MK; Kobayashi, H; Paik, CH; Paik, DS; Pie, JE; Waldmann, TA; Yao, Z | 1 |
Mukhopadhyay, T; Nakamura, S; Roth, JA | 1 |
Martino, G; Ventafridda, V | 1 |
Bojan, O; Kiricuta, I | 1 |
Ax, W; Bauer, HW | 1 |
Hempel, K; Lange, HW; Löwer, R | 1 |
Anderson, RL; Hahn, GM; Kapp, DS; Krag, DN; Rice, GC; van Kersen, I; Woo, SY | 1 |
Cacciatore, L; Fabris, N; Lingetti, M; Mocchegiani, E; Talarico, M | 1 |
Hahn, GM; Kapp, DS; Rice, GC; Woo, SY | 1 |
Abergel, A; Amiot, JF; Babinet, P; Boule, D; Glowinski, J; Hardy, F; Mechali, D; Palacci, JH; Pellerin, M; Wingtin, LN | 1 |
Farcot, JM; Laugner, B; Muller, A; Thiébaut, JB | 1 |
Gabrielli, F; Tsugita, A | 1 |
Brennan, MF; Burt, ME; Gorschboth, CM; Norton, JA; Wesley, RA | 1 |
Le Grignou, P; Michelet, FX; Pinsolle, J | 1 |
Laki, K | 1 |
Eisen, HN | 1 |
Al-Sarraf, M; Belamaric, J; Cejka, J; Kithier, K; Peterson, WD; Poulik, MD; Vaitkevicius, VK | 1 |
Bottici, R; Ferrucci, A; Taddeucci, E | 1 |
Berke, G; Stulting, RD | 1 |
Balhorn, M; Balhorn, R; Chalkley, R; Morris, HP | 1 |
Hersh, EM; Ohno, R | 1 |
Bürgi, W; Schärer, HU | 1 |
ROZHEK, IS | 1 |
PUSHKAR, LN | 1 |
99 review(s) available for lysine and Benign Neoplasms
Article | Year |
---|---|
Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase.
Topics: Animals; Carcinogenesis; Chromatin; Genomic Instability; Histones; Humans; Lysine; Mammals; Methylation; Neoplasms | 2022 |
Emerging roles of JMJD3 in cancer.
Topics: Apoptosis; Female; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Neoplasms | 2022 |
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.
Topics: Chromatin; Histone Demethylases; Histones; Humans; Lysine; Neoplasms | 2022 |
Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer.
Topics: Animals; Epigenesis, Genetic; Histone Demethylases; Histone Methyltransferases; Histones; Humans; Lysine; Neoplasms; Polycomb-Group Proteins | 2022 |
Regulation of epithelial-mesenchymal transition by protein lysine acetylation.
Topics: Acetylation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Histones; Humans; Lysine; Neoplasms | 2022 |
Promising natural lysine specific demethylase 1 inhibitors for cancer treatment: advances and outlooks.
Topics: Antineoplastic Agents; Enzyme Inhibitors; Histone Demethylases; Humans; Lysine; Neoplasms | 2022 |
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy.
Topics: Acetylation; Humans; Immunotherapy; Lysine; Neoplasms; Protein Processing, Post-Translational | 2022 |
Monoubiquitination in Homeostasis and Cancer.
Topics: Homeostasis; Humans; Lysine; Neoplasms; Protein Processing, Post-Translational; Ubiquitin; Ubiquitination | 2022 |
Chemical biology and pharmacology of histone lysine methylation inhibitors.
Topics: Biology; Epigenesis, Genetic; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Methylation; Neoplasms; Protein Processing, Post-Translational | 2022 |
Targeting histone demethylases as a potential cancer therapy (Review).
Topics: Histone Demethylases; Histones; Humans; Lysine; Methylation; Neoplasms | 2022 |
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.
Topics: Humans; Lysine; Neoplasms; Peptides; Sirtuins; Structure-Activity Relationship | 2022 |
Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
Topics: DNA Methylation; Epigenesis, Genetic; Histone Demethylases; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms | 2022 |
Protein Lysine Methyltransferases Inhibitors.
Topics: Epigenesis, Genetic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methyltransferases; Neoplasms; Protein Processing, Post-Translational | 2023 |
NSD2 as a Promising Target in Hematological Disorders.
Topics: Epigenesis, Genetic; Hematologic Diseases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Neoplasms; Repressor Proteins | 2022 |
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
Topics: Histones; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Lactic Acid; Lysine; Neoplasms; Tumor Microenvironment; Waste Products | 2022 |
Metabolic Regulation of Lysine Acetylation: Implications in Cancer.
Topics: Acetyl Coenzyme A; Acetylation; Humans; Lysine; NAD; Neoplasms; Protein Processing, Post-Translational | 2022 |
A review of the mechanism of succinylation in cancer.
Topics: Humans; Lysine; Neoplasms; Protein Processing, Post-Translational; Signal Transduction; Succinic Acid | 2022 |
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination.
Topics: Epigenesis, Genetic; Glycolysis; Humans; Lactic Acid; Lysine; Neoplasms | 2023 |
The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy.
Topics: Carcinogenesis; Histone Demethylases; Histones; Humans; Lysine; Neoplasms | 2023 |
Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy.
Topics: Chromatin; Histone Demethylases; Histones; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms | 2023 |
Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases.
Topics: DNA-Binding Proteins; Epigenesis, Genetic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Neoplasms; Transcription Factors | 2023 |
The role and prospect of lysine-specific demethylases in cancer chemoresistance.
Topics: Drug Resistance, Neoplasm; Histone Demethylases; Histones; Humans; Lysine; Neoplasms | 2023 |
Prospect of targeting lysine methyltransferase NSD3 for tumor therapy.
Topics: Humans; Lysine; Neoplasms | 2023 |
Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential.
Topics: Histone Demethylases; Histones; Humans; Immunotherapy; Lysine; Neoplasms; Tumor Microenvironment | 2023 |
Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer.
Topics: Bromodomain Containing Proteins; Chromatin; Epigenesis, Genetic; Histones; Humans; Lysine; Neoplasms | 2023 |
Shuttle between arginine and lysine: influence on cancer immunonutrition.
Topics: Amino Acids; Arginine; Diet; Immunonutrition Diet; Lysine; Neoplasms | 2023 |
Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
Topics: Histone Demethylases; Histones; Humans; Lysine; Neoplasms | 2023 |
Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer.
Topics: Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Histones; Humans; Lysine; Neoplasms; Polycomb Repressive Complex 2; Yin-Yang; YY1 Transcription Factor | 2023 |
Lysine Methylation Regulators Moonlighting outside the Epigenome.
Topics: Animals; Epigenome; Humans; Lysine; Methylation; Neoplasm Proteins; Neoplasms; Protein Processing, Post-Translational; Signal Transduction | 2019 |
Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg.
Topics: Chromosomal Proteins, Non-Histone; Gene Expression Regulation, Neoplastic; Histone Demethylases; Histones; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Jumonji Domain-Containing Histone Demethylases; Lysine; Methylation; Neoplasms; Protein Processing, Post-Translational; Signal Transduction | 2020 |
N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.
Topics: Acyltransferases; Animals; Communicable Diseases; Enzyme Inhibitors; Glycine; Humans; Immunity, Innate; Lysine; Neoplasms; Protein Processing, Post-Translational; Proteins | 2020 |
Complex functions of Gcn5 and Pcaf in development and disease.
Topics: Acetylation; Adaptive Immunity; Animals; Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Embryonic Development; Embryonic Stem Cells; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Humans; Immunity, Innate; Lysine; Mice; Mice, Transgenic; Mutation; Neoplasms; p300-CBP Transcription Factors | 2021 |
Clinicopathologic significance of protein lysine methyltransferases in cancer.
Topics: Adolescent; Adult; Clinical Trials as Topic; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Epigenomics; Female; Histone-Lysine N-Methyltransferase; Histones; Humans; Immunohistochemistry; Lysine; Neoplasm Staging; Neoplasms; Survival Analysis; Young Adult | 2020 |
Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Topics: Carcinogenesis; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Neoplasm Proteins; Neoplasms; Protein Processing, Post-Translational; Repressor Proteins; Transcription, Genetic | 2021 |
Methylation of histone 4's lysine 20: a critical analysis of the state of the field.
Topics: Animals; Cell Cycle; Embryonic Development; Histones; Humans; Lysine; Methylation; Neoplasms | 2021 |
The GCN5: its biological functions and therapeutic potentials.
Topics: Acetylation; Animals; Antineoplastic Agents; Chromatin Assembly and Disassembly; Enzyme Inhibitors; Epigenesis, Genetic; Histone Acetyltransferases; Histones; Humans; Lysine; Molecular Targeted Therapy; Neoplasms; Protein Domains; Protein Processing, Post-Translational; Structure-Activity Relationship; Substrate Specificity | 2021 |
An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives.
Topics: Drug Discovery; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lysine; Neoplasms | 2021 |
Coordinated methyl readers: Functional communications in cancer.
Topics: Histones; Humans; Lysine; Methylation; Methyltransferases; Neoplasms | 2022 |
Biomolecular labeling based on lysine-clickable 6π-azaelectrocyclization toward innovative cancer theranostics.
Topics: Animals; Antineoplastic Agents; Azides; Click Chemistry; Cyclization; Dose-Response Relationship, Drug; Humans; Lysine; Mice; Molecular Structure; Neoplasms; Positron-Emission Tomography; Structure-Activity Relationship; Theranostic Nanomedicine | 2021 |
The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Adult; Aminocaproic Acid; Blood Loss, Surgical; Blood Transfusion; Erythrocyte Transfusion; Humans; Lysine; Neoplasms; Patient Safety; Platelet Transfusion; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome; Venous Thrombosis | 2017 |
Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.
Topics: Epigenesis, Genetic; Genomics; Humans; Inflammation; Lysine; Neoplasms | 2017 |
Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
Topics: Cell Movement; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Histone Demethylases; Humans; Lysine; Neoplasms | 2017 |
Disrupting Acetyl-lysine Interactions: Recent Advance in the Development of BET Inhibitors.
Topics: Acetylation; Animals; Antineoplastic Agents; Cell Cycle Proteins; Drug Development; Histones; Humans; Lysine; Models, Molecular; Neoplasms; Nuclear Proteins; Protein Conformation; Protein Processing, Post-Translational; Proteins; Structure-Activity Relationship; Transcription Factors | 2018 |
Photochemical Activation of Enediyne Warheads: A Potential Tool for Targeted Antitumor Therapy.
Topics: Antibiotics, Antineoplastic; Cyclization; DNA Damage; DNA, Neoplasm; Enediynes; Humans; Light; Lysine; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Photochemotherapy | 2018 |
Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
Topics: Acetylation; Animals; Histone Acetyltransferases; Humans; Lysine; Neoplasms; p300-CBP Transcription Factors; Protein Processing, Post-Translational | 2019 |
[Progress in roles and mechanisms of deacetylase SIRT7].
Topics: Animals; Histones; Humans; Lysine; Neoplasms; Signal Transduction; Sirtuins | 2019 |
Lysine methylation of transcription factors in cancer.
Topics: Antineoplastic Agents; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Neoplasms; Protein Processing, Post-Translational; Protein Stability; Transcription Factors | 2019 |
Protein lysine acetylation guards metabolic homeostasis to fight against cancer.
Topics: Acetylation; Carcinogenesis; Genes, Neoplasm; Homeostasis; Humans; Lysine; Mitochondria; Neoplasms; Sirtuins | 2014 |
Decoding the histone code: Role of H3K36me3 in mismatch repair and implications for cancer susceptibility and therapy.
Topics: Base Pair Mismatch; Histone Code; Humans; Lysine; Methylation; Neoplasms; Polycomb Repressive Complex 2 | 2013 |
The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle.
Topics: Animals; Cell Cycle; Cellular Reprogramming; Chromatin; DNA Damage; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Methyltransferases; Neoplasms | 2014 |
The bromodomain: from epigenome reader to druggable target.
Topics: Acetylation; Cardiovascular Diseases; Epigenesis, Genetic; Histones; HIV Infections; Humans; Lysine; Models, Molecular; Neoplasms; Protein Conformation; Protein Interaction Domains and Motifs; Protein Processing, Post-Translational; Protein Structure, Tertiary; Small Molecule Libraries; Transcription Factors | 2014 |
Examining the impact of gene variants on histone lysine methylation.
Topics: Animals; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Mutation; Neoplasms; Polymorphism, Single Nucleotide | 2014 |
Sumoylation of hypoxia inducible factor-1α and its significance in cancer.
Topics: Amino Acid Sequence; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ligases; Lysine; Molecular Sequence Data; Neoplasms; Polycomb-Group Proteins; Sumoylation; Ubiquitin-Protein Ligases | 2014 |
Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diabetes Mellitus; Disease Progression; Humans; Inflammation; Ligands; Lysine; Melanoma; Mice; Neoplasm Metastasis; Neoplasms; Oxidative Stress; Receptor for Advanced Glycation End Products; Risk Factors; Treatment Outcome | 2015 |
Targeting histone lysine methylation in cancer.
Topics: Animals; Antineoplastic Agents; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Molecular Targeted Therapy; Neoplasms; Signal Transduction | 2015 |
KATs in cancer: functions and therapies.
Topics: Animals; Enzyme Inhibitors; Histone Acetyltransferases; Humans; Lysine; Neoplasms | 2015 |
Epigenetic regulation by histone demethylases in hypoxia.
Topics: Cardiovascular Diseases; Epigenesis, Genetic; Histones; Humans; Hypoxia; Jumonji Domain-Containing Histone Demethylases; Lysine; Methylation; Models, Genetic; Neoplasms | 2015 |
The translation factor eIF5A and human cancer.
Topics: Eukaryotic Translation Initiation Factor 5A; Gene Expression Regulation; Humans; Lysine; Neoplasms; Oncogene Proteins; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Peptide Initiation Factors; Protein Isoforms; Protein Processing, Post-Translational; RNA-Binding Proteins | 2015 |
JMJD3 as an epigenetic regulator in development and disease.
Topics: Animals; Chromatin; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation, Developmental; Germ Layers; Histone Demethylases; Histones; Humans; Immunity, Innate; Jumonji Domain-Containing Histone Demethylases; Lysine; Mice; Neoplasms; Neurodegenerative Diseases; Nuclear Proteins; Polycomb Repressive Complex 2 | 2015 |
Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation.
Topics: Biological Availability; Bone Diseases; Diet; Food; Food Contamination; Food Handling; Glycation End Products, Advanced; Hot Temperature; Humans; Lysine; Maillard Reaction; Neoplasms; Neurodegenerative Diseases; Oxidative Stress | 2016 |
Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics.
Topics: Acetylation; Animals; Antineoplastic Agents; Carcinogenesis; Humans; Lysine; Lysine Acetyltransferases; Neoplasms | 2016 |
The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target.
Topics: Acetylation; Acetyltransferases; Animals; Biomarkers; Humans; Lysine; Lysine Acetyltransferases; Mice; Microtubule Proteins; Neoplasms; p300-CBP Transcription Factors; Prognosis; Protein Processing, Post-Translational | 2016 |
Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
Topics: Animals; Biogenic Polyamines; Eukaryotic Translation Initiation Factor 5A; Humans; Lysine; Mixed Function Oxygenases; Neoplasm Proteins; Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Peptide Initiation Factors; Protein Processing, Post-Translational; RNA-Binding Proteins | 2016 |
Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy.
Topics: Antineoplastic Agents; Histones; Humans; Lysine; Methylation; Neoplasms | 2016 |
H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.
Topics: Animals; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Neoplasms; Transcription Factors | 2016 |
Nonhistone Lysine Methylation in the Regulation of Cancer Pathways.
Topics: Cell Transformation, Neoplastic; Chromosomal Proteins, Non-Histone; DNA Damage; Epigenesis, Genetic; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Neoplasms; Protein Processing, Post-Translational; Signal Transduction | 2016 |
Lysine acetylation and cancer: A proteomics perspective.
Topics: Acetylation; Humans; Lysine; Neoplasms; Nuclear Proteins; Protein Processing, Post-Translational; Proteomics | 2017 |
The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Chromatin; Epigenesis, Genetic; Evolution, Molecular; Gene Duplication; Histones; Humans; Lysine; Multigene Family; Neoplasms; Protein Domains; Protein Isoforms; Protein Serine-Threonine Kinases; Signal Transduction; Transcription Factors; Virus Diseases | 2016 |
Bromodomain inhibitors and cancer therapy: From structures to applications.
Topics: Acetylation; Antineoplastic Agents; Chromatin; Epigenesis, Genetic; Histone Acetyltransferases; Histone Chaperones; Histone Code; Humans; Lysine; Neoplasms; Nuclear Proteins; Protein Domains | 2017 |
Functions of bromodomain-containing proteins and their roles in homeostasis and cancer.
Topics: Acylation; Animals; Chromatin Assembly and Disassembly; Gene Expression Regulation; Histones; Homeostasis; Humans; Lysine; Mutation; Neoplasms; Oncogene Proteins, Fusion; Protein Domains; Protein Processing, Post-Translational; Proteins; Tumor Suppressor Proteins | 2017 |
The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.
Topics: Animals; Carcinogenesis; Catalysis; Fanconi Anemia; Gene Expression Regulation, Neoplastic; Homeostasis; Humans; Lysine; Neoplasms; NF-kappa B; Oncogenes; Protein Processing, Post-Translational; Protein Transport; Proteolysis; Proto-Oncogene Proteins c-akt; Signal Transduction; Ubiquitin; Ubiquitination | 2017 |
Dynamic protein methylation in chromatin biology.
Topics: Animals; Arginine; Chromatin; DNA Damage; Embryonic Stem Cells; Epigenesis, Genetic; Gene Expression Regulation; Germ Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Lysine; Methylation; Models, Molecular; Molecular Structure; Neoplasms; Oxidoreductases, N-Demethylating; Protein Conformation; Protein Methyltransferases; Protein Processing, Post-Translational; Tumor Suppressor Protein p53 | 2009 |
Biomarkers for predicting clinical responses to HDAC inhibitors.
Topics: Acetylation; Antineoplastic Agents; Biomarkers, Tumor; Clinical Trials as Topic; Gene Expression Profiling; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lysine; Neoplasms; Predictive Value of Tests | 2009 |
The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
Topics: Arginine; Enzyme Inhibitors; Histone Demethylases; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Neoplasms; Protein Processing, Post-Translational | 2009 |
Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammation.
Topics: Animals; Humans; Immunotherapy; Inflammation; Lysine; Models, Biological; Neoplasms; NF-kappa B; Polyubiquitin; Protein Processing, Post-Translational; Signal Transduction; Ubiquitin; Ubiquitination | 2009 |
Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.
Topics: Animals; Cell Transformation, Neoplastic; Enzyme Activation; Humans; Lysine; Neoplasms; Phosphoric Monoester Hydrolases; Protein Kinases; Ubiquitination | 2010 |
Errors in erasure: links between histone lysine methylation removal and disease.
Topics: Animals; Cathepsin L; Cell Cycle Proteins; Histone Chaperones; Histone Demethylases; Histones; Humans; Lysine; Methylation; Neoplasms; Transcription Factors | 2011 |
Deacetylation of nonhistone proteins by HDACs and the implications in cancer.
Topics: Acetylation; Animals; Apoptosis; Autophagy; Cell Differentiation; DNA Damage; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Humans; Lysine; Neoplasm Invasiveness; Neoplasms; Protein Processing, Post-Translational | 2011 |
Alterations in histone H4 lysine 20 methylation: implications for cancer detection and prevention.
Topics: Animals; Epigenesis, Genetic; Epigenomics; Histones; Humans; Lysine; Methylation; Neoplasms | 2012 |
Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
Topics: Acetylation; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lysine; Neoplasms; Vorinostat | 2010 |
eIF5A isoforms and cancer: two brothers for two functions?
Topics: Animals; Apoptosis; Cell Transformation, Neoplastic; Eukaryotic Translation Initiation Factor 5A; Gene Expression; Humans; Lysine; Neoplasms; Peptide Initiation Factors; Protein Isoforms; RNA-Binding Proteins | 2013 |
Modulation of cell cycle regulators by HDACs.
Topics: Cell Cycle; Cell Cycle Proteins; Cell Growth Processes; Histone Deacetylases; Histones; Humans; Lysine; Neoplasms | 2012 |
Oncoepigenomics: making histone lysine methylation count.
Topics: Animals; Epigenomics; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Neoplasms | 2012 |
Tipping the lysine methylation balance in disease.
Topics: Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Mutation; Neoplasms; Nervous System Diseases | 2013 |
Proteasome inhibition: a new anti-inflammatory strategy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Asthma; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cysteine Endopeptidases; Disease Models, Animal; Humans; Inflammation; Lysine; Models, Biological; Models, Chemical; Multienzyme Complexes; Multiple Sclerosis; Neoplasms; NF-kappa B; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Psoriasis; Pyrazines; Reperfusion Injury | 2003 |
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.
Topics: Acetylation; Acetyltransferases; Humans; Leukemia; Lysine; Neoplasms; Protein Structure, Tertiary; Proteins; Substrate Specificity | 2004 |
SUMO: a ubiquitin-like protein modifier.
Topics: Animals; Cell Cycle; Chromosomes; DNA Damage; Humans; Inflammation; Lysine; Neoplasms; Protein Binding; Saccharomyces cerevisiae; SUMO-1 Protein; Ubiquitin | 2005 |
Pharmacological targeting of lysine acetyltransferases in human disease: a progress report.
Topics: Acetyltransferases; Curcumin; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Humans; Lysine; Models, Molecular; Molecular Structure; Neoplasms | 2007 |
Histidine-lysine peptides as carriers of nucleic acids.
Topics: Angiostatic Proteins; Animals; DNA; Gene Expression Regulation, Neoplastic; Genetic Therapy; Histidine; Humans; Lysine; Neoplasms; Neovascularization, Pathologic; Nucleic Acid Conformation; Peptides; Protein Conformation; RNA Interference; RNA, Small Interfering; Transfection; Tumor Burden | 2007 |
The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection.
Topics: Animals; Caenorhabditis elegans Proteins; Cell Transformation, Neoplastic; DNA-Binding Proteins; Drosophila melanogaster; Drosophila Proteins; Epigenesis, Genetic; Gene Expression Regulation; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Jumonji Domain-Containing Histone Demethylases; Lysine; Mammals; Methylation; Mice; Mice, Knockout; Neoplasms; Nuclear Proteins; Nucleosomes; Oxidoreductases, N-Demethylating; Protein Processing, Post-Translational; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; Repressor Proteins; Retinoblastoma-Binding Protein 2; Saccharomyces cerevisiae Proteins; Substrate Specificity; Tumor Suppressor Proteins | 2007 |
NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
Topics: Acetylation; Aging; Diabetes Mellitus; Histone Deacetylases; Histones; Humans; Lysine; NAD; Neoplasms; Sirtuins | 2007 |
Histone lysine demethylases: emerging roles in development, physiology and disease.
Topics: Amino Acid Sequence; Animals; Gene Expression Regulation, Developmental; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Molecular Sequence Data; Neoplasms; Nervous System Diseases | 2007 |
[Research progress on the relationship between nutrition and cancer epigenetics---histone modification mechanisms].
Topics: Acetylation; Biotinylation; DNA, Neoplasm; Epigenesis, Genetic; Histones; Humans; Lysine; Methylation; Neoplasms; Nutritional Physiological Phenomena; Phosphorylation; Poly Adenosine Diphosphate Ribose | 2007 |
[Biological diversity of protein lysine acetylation which has been revealed by small molecule inhibitors].
Topics: Acetylation; Animals; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Cortactin; Enzyme Inhibitors; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Lysine; mRNA Cleavage and Polyadenylation Factors; Neoplasms; Tubulin; Tumor Suppressor Protein p53 | 2007 |
Polyamines.
Topics: Adenosylmethionine Decarboxylase; Animals; Arginase; Aspergillus nidulans; Carboxy-Lyases; Cloning, Molecular; DNA; Escherichia coli; Lysine; Mutation; Neoplasms; Neurospora crassa; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Physarum; Plants; Polyamines; Protein Biosynthesis; Protein Kinases; Protein Processing, Post-Translational; Putrescine; RNA; Saccharomyces cerevisiae; Spermidine; Spermidine Synthase; Spermine; Spermine Synthase | 1984 |
No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer.
Topics: Angiogenesis Inhibitors; Angiostatins; Antineoplastic Agents; Carboxypeptidase B2; Carboxypeptidases; Collagen; Endostatins; Humans; Lysine; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Plasminogen; Plasminogen Activators; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 2000 |
Histone methylation versus histone acetylation: new insights into epigenetic regulation.
Topics: Acetylation; Animals; Chromobox Protein Homolog 5; Chromosomal Proteins, Non-Histone; DNA Methylation; Gene Expression Regulation, Developmental; Gene Silencing; Heterochromatin; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Methyltransferases; Neoplasms; Protein Methyltransferases; Transcription, Genetic | 2001 |
Acetyllysine-binding and function of bromodomain-containing proteins in chromatin.
Topics: Acetyltransferases; Amino Acid Motifs; Animals; Binding Sites; Chromatin; Histone Acetyltransferases; Histones; Humans; Lysine; Mutation; Neoplasms; Nuclear Proteins; Protein Structure, Tertiary; Saccharomyces cerevisiae Proteins; Terminology as Topic; Transcription, Genetic | 2001 |
The bromodomain: a chromatin browser?
Topics: Acetyltransferases; Amino Acid Sequence; Animals; Chromatin; Histone Acetyltransferases; Humans; Lysine; Molecular Sequence Data; Mutation; Neoplasms; Nuclear Proteins; Oncogene Proteins, Fusion; Protein Structure, Tertiary; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Transcription, Genetic | 2001 |
1 trial(s) available for lysine and Benign Neoplasms
Article | Year |
---|---|
[First results of the clinical use of injectable lysine acetylsalicylate].
Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Drug Combinations; Evaluation Studies as Topic; Female; Glycine; Headache; Humans; Injections, Intramuscular; Injections, Intravenous; Joint Diseases; Lysine; Male; Middle Aged; Neoplasms; Neuritis; Osteoarthritis; Pain | 1972 |
225 other study(ies) available for lysine and Benign Neoplasms
Article | Year |
---|---|
Hypoxia-activated KDAC inhibitor: Taking a breath from untargeted therapy.
Topics: Animals; Histone Deacetylases; Hypoxia; Lysine; Neoplasms; Prodrugs | 2021 |
"Clickable" Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals.
Topics: Albumins; Animals; Copper Radioisotopes; Lysine; Mice; Neoplasms; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2022 |
Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Topics: Drug Resistance, Neoplasm; Histone Demethylases; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Neoplasms; Transcription Factors | 2022 |
PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
Topics: Adaptor Proteins, Signal Transducing; Humans; Lipid Metabolism; Lysine; Neoplasms; Protein-Arginine N-Methyltransferases; Sirtuins; Sterol Regulatory Element Binding Protein 1; Ubiquitin-Protein Ligases | 2022 |
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.
Topics: Acetylation; Acetyltransferases; Enzyme Inhibitors; Histone Acetyltransferases; Histones; Humans; Lysine; Neoplasms; Pyrazines; Structure-Activity Relationship | 2022 |
Structural and dynamic determinants for highly selective RET kinase inhibition reveal cryptic druggability.
Topics: Humans; Lysine; Molecular Conformation; Molecular Dynamics Simulation; Neoplasms; Proto-Oncogene Proteins c-ret | 2023 |
Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A.
Topics: Demethylation; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms; Protein Processing, Post-Translational | 2022 |
Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy.
Topics: Antineoplastic Agents; Arginine; Camptothecin; Cell Line, Tumor; Humans; Lactones; Lysine; Mitochondria; Neoplasms; Prodrugs; Reactive Oxygen Species; Water | 2022 |
Impact of Radiolabeling Strategies on the Pharmacokinetics and Distribution of an Anti-PD-L1 PET Ligand.
Topics: Amides; Animals; B7-H1 Antigen; Cell Line, Tumor; Fluorine Radioisotopes; Immunoglobulin Fragments; Ligands; Ligases; Lysine; Mice; Neoplasms; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Thioctic Acid; Tissue Distribution | 2022 |
Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.
Topics: Adjuvants, Immunologic; Cancer Vaccines; CD8-Positive T-Lymphocytes; DNA; Epitopes; Humans; Hydrogels; Immunoglobulin G; Interferons; Lysine; Neoplasms; Phosphorus; Receptors, Pattern Recognition | 2022 |
The histone methyltransferase SETD2 negatively regulates cell size.
Topics: Cell Size; Histone Methyltransferases; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms; RNA Polymerase II; Tumor Suppressor Proteins | 2022 |
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase.
Topics: Animals; HEK293 Cells; Humans; Lysine; Mice; Neoplasms; Sirtuins | 2022 |
Type I interferon induces cancer stem cells-mediated chemotherapy resistance.
Topics: Interferon Type I; Lysine; Neoplasms; Neoplastic Stem Cells | 2022 |
Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization.
Topics: Acidosis; Animals; Cell Line, Tumor; Glutamic Acid; Gold; Hypoxia; Lysine; Mice; Nanotubes; Neoplasms; Tumor Microenvironment | 2022 |
Combination of Se-methylselenocysteine, D-α-tocopheryl succinate, β-carotene, and L-lysine can prevent cancer metastases using as an adjuvant therapy.
Topics: alpha-Tocopherol; Animals; Antioxidants; Apoptosis; beta Carotene; Cell Line, Tumor; Cell Proliferation; Lysine; Mice; Neoplasms; Paclitaxel; Quality of Life; Succinates | 2022 |
Lasso peptide microcin J25 variant containing RGD motif as a PET probe for integrin a v ß 3 in tumor imaging.
Topics: Animals; Escherichia coli; Integrin alphaVbeta3; Lysine; Mice; Molecular Probes; Neoplasms; Positron-Emission Tomography; Tissue Distribution | 2023 |
Pyrazolone derivatives as potent and selective small-molecule SIRT5 inhibitors.
Topics: Humans; Lysine; NAD; Neoplasms; Pyrazolones; Sirtuins | 2023 |
Histone tail electrostatics modulate E2-E3 enzyme dynamics: a gateway to regulate ubiquitination machinery.
Topics: Histones; Humans; Lysine; Neoplasms; Nucleosomes; Static Electricity; Ubiquitin-Conjugating Enzymes; Ubiquitin-Protein Ligases; Ubiquitination | 2023 |
New K50R mutant mouse models reveal impaired hypusination of eif5a2 with alterations in cell metabolite landscape.
Topics: Animals; Gene Expression; Humans; Lysine; Mice; Neoplasms | 2023 |
Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner.
Topics: Acetyltransferases; Acylation; Epigenesis, Genetic; Humans; Lysine; N-Terminal Acetyltransferases; Neoplasms; Protein Processing, Post-Translational; Ubiquitin-Specific Proteases | 2023 |
Comparison of Human Eukaryotic Translation Initiation Factors 5A1 and 5AL1: Identification of Amino Acid Residues Important for EIF5A1 Lysine 50 Hypusination and Its Protein Stability.
Topics: Amino Acids; Eukaryotic Initiation Factors; Eukaryotic Translation Initiation Factor 5A; Humans; Lysine; Neoplasms; Peptide Initiation Factors; Protein Stability | 2023 |
The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
Topics: Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Mutation; Neoplasms | 2023 |
Lysine catabolism reprograms tumour immunity through histone crotonylation.
Topics: Animals; Chromatin; Glutaryl-CoA Dehydrogenase; Histones; Humans; Interferon Type I; Lysine; Mice; Neoplasms; Protein Processing, Post-Translational; RNA, Double-Stranded | 2023 |
RAFT Polymer-Antibody Conjugation: Squaramide Ester Chemistry Leads to Conjugates with a Therapeutic Anti-EGFR Antibody with Full Retention of Activity and Increased Tumor Uptake
Topics: Animals; Antibodies; Humans; Lysine; Mice; Neoplasms; Polymers; Proteins; Reproducibility of Results | 2023 |
Lysine metabolism at the nexus of crotonylation and tumor immunity.
Topics: Histones; Humans; Lysine; Neoplasms; Protein Processing, Post-Translational | 2023 |
Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.
Topics: Drosophila Proteins; Histones; Humans; Lysine; Neoplasms; Nucleosomes; Polycomb-Group Proteins; Repressor Proteins; Tumor Suppressor Proteins; Ubiquitin Thiolesterase | 2023 |
CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells.
Topics: Animals; Ligases; Lysine; Mice; Mice, Knockout; Neoplasms; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Programmed Cell Death 1 Receptor; T-Lymphocytes | 2023 |
NSD2 methylates AROS to promote SIRT1 activation and regulates fatty acid metabolism-mediated cancer radiotherapy.
Topics: Carcinogenesis; Fatty Acids; Histone-Lysine N-Methyltransferase; Humans; Lysine; Neoplasms; Repressor Proteins; Sirtuin 1 | 2023 |
Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma.
Topics: Acetylation; Biomarkers; Epigenesis, Genetic; Histones; Humans; Lymphoma, Non-Hodgkin; Lysine; Neoplasms; Nucleosomes; Protein Processing, Post-Translational | 2023 |
Rare de novo gain-of-function missense variants in DOT1L are associated with developmental delay and congenital anomalies.
Topics: Congenital Abnormalities; Developmental Disabilities; Drosophila; Drosophila Proteins; Gain of Function Mutation; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Methyltransferases; Neoplasms | 2023 |
Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer.
Topics: Breast Neoplasms; Female; Histones; Humans; Immunotherapy; Lactic Acid; Lysine; Neoplasms; Prognosis; Tumor Microenvironment | 2023 |
RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.
Topics: Autophagy; Autophagy-Related Protein 7; Autophagy-Related Protein-1 Homolog; Cell Proliferation; DNA Polymerase III; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Homologous Recombination; Humans; Intracellular Signaling Peptides and Proteins; Ligases; Lysine; Neoplasms; Nucleotidyltransferases; Protein Stability; Rad52 DNA Repair and Recombination Protein; RNA-Binding Proteins; Signal Transduction; Sumoylation; Telomere; Telomere Homeostasis | 2019 |
MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer.
Topics: Genetic Predisposition to Disease; Glutamic Acid; Humans; Lysine; Matrix Metalloproteinase 8; Neoplasms; Polymorphism, Single Nucleotide; Threonine | 2019 |
Molecular insights on cytochrome c and nucleotide regulation of apoptosome function and its implication in cancer.
Topics: Alanine; Amino Acid Substitution; Apoptosomes; Apoptotic Protease-Activating Factor 1; Case-Control Studies; Cell Transformation, Neoplastic; Cells, Cultured; Cytochromes c; Female; Humans; Lysine; Male; Models, Molecular; Molecular Docking Simulation; Mutant Proteins; Neoplasms; Nucleotides; PC-3 Cells; Protein Binding; Protein Interaction Mapping; Protein Multimerization; Signal Transduction | 2020 |
Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody-Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Benzodiazepines; Cell Line, Tumor; Female; Humans; Immunoconjugates; Lysine; Mice; Mice, SCID; Neoplasms; Oxindoles; Therapeutic Index | 2020 |
Histone Lysine Methylation Dynamics Control
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; DNA Copy Number Variations; DNA Methylation; Epigenesis, Genetic; ErbB Receptors; Gene Amplification; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms; Protein Kinase Inhibitors | 2020 |
Aspirin Reshapes Acetylomes in Inflammatory and Cancer Cells via CoA-Dependent and CoA-Independent Pathways.
Topics: Acetyl Coenzyme A; Acetylation; Aspirin; Humans; Lysine; Neoplasms; Protein Processing, Post-Translational; Proteome | 2020 |
A novel EZH2 inhibitor induces synthetic lethality and apoptosis in PBRM1-deficient cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Indoles; Lysine; Methylation; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; Prognosis; Pyridones; Reproducibility of Results; Synthetic Lethal Mutations; Transcription Factors | 2020 |
Immunotoxin SS1P is rapidly removed by proximal tubule cells of kidney, whose damage contributes to albumin loss in urine.
Topics: Albuminuria; Animals; Antibodies, Monoclonal; Capillary Leak Syndrome; Disease Models, Animal; Female; Fluorescent Dyes; Half-Life; Humans; Immunotoxins; Intravital Microscopy; Kidney Glomerulus; Kidney Tubules, Proximal; Lysine; Mesothelin; Mice; Microscopy, Fluorescence; Neoplasms; Recombinant Proteins; Renal Elimination; Serum Albumin; Staining and Labeling | 2020 |
SUMOylation modulates the LIN28A-let-7 signaling pathway in response to cellular stresses in cancer cells.
Topics: Animals; Carcinogenesis; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lysine; Mice, Nude; MicroRNAs; Mutation; Neoplasms; Protein Binding; RNA-Binding Proteins; Signal Transduction; Stress, Physiological; Sumoylation; Uridine | 2020 |
Host-Guest Protein Assembly for Affinity Purification of Methyllysine Proteomes.
Topics: Amantadine; Bridged-Ring Compounds; Chromatography, Affinity; Chromobox Protein Homolog 5; Chromosomal Proteins, Non-Histone; HeLa Cells; Humans; Imidazoles; Lysine; Methylation; Neoplasms; Peptides | 2020 |
HybridSucc: A Hybrid-learning Architecture for General and Species-specific Succinylation Site Prediction.
Topics: Acylation; Algorithms; Amino Acid Sequence; Area Under Curve; Humans; Lysine; Machine Learning; Neoplasms; Proteins; Proteome; ROC Curve; Species Specificity; Succinic Acid | 2020 |
On-chip protein separation with single-molecule resolution.
Topics: Acrylic Resins; Calibration; Cell Line, Tumor; Cysteine; Electrophoresis, Polyacrylamide Gel; Humans; Lysine; Molecular Weight; Neoplasms; Protein Array Analysis; Proteins; Proteomics; Sodium Dodecyl Sulfate | 2020 |
Deep learning based prediction of reversible HAT/HDAC-specific lysine acetylation.
Topics: Acetylation; Datasets as Topic; Deep Learning; Histone Deacetylases; Humans; Internet; Lysine; Neoplasms | 2020 |
Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance.
Topics: Acetylation; Cell Line, Tumor; GPI-Linked Proteins; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Mutation; Neoplasm Transplantation; Neoplasms; NK Cell Lectin-Like Receptor Subfamily K; Nuclear Matrix-Associated Proteins; Nucleocytoplasmic Transport Proteins; p300-CBP Transcription Factors; Protein Stability; Survival Analysis; Tissue Array Analysis; Tumor Escape | 2021 |
Heritable pattern of oxidized DNA base repair coincides with pre-targeting of repair complexes to open chromatin.
Topics: Acetylation; Animals; Cell Line, Tumor; Cell Nucleus; Chromatin; Datasets as Topic; DNA Glycosylases; DNA Repair; Evolution, Molecular; Genes, Helminth; Genes, Homeobox; HEK293 Cells; Helminth Proteins; Humans; Invertebrates; Lysine; Mutation; Neoplasm Proteins; Neoplasms; Oxidation-Reduction; Protein Processing, Post-Translational; Proteome; Sequence Alignment; Sequence Homology, Amino Acid; Transcription Initiation Site; Vertebrates | 2021 |
mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.
Topics: Acetylation; Animals; Carcinogenesis; Cell Cycle Checkpoints; Embryo, Mammalian; Lysine; Mice; Mutation; Neoplasms; Proto-Oncogene Proteins c-mdm2; Sirolimus; Survival Analysis; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2021 |
FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells.
Topics: Adult; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Breaks, Double-Stranded; DNA Replication; Drug Resistance, Neoplasm; F-Box Proteins; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Immune Checkpoint Inhibitors; Immunity; Interferons; Lysine; Male; Methylation; Middle Aged; Neoplasm Proteins; Neoplasms; Nucleosomes; Repetitive Sequences, Nucleic Acid; Signal Transduction; Transcription, Genetic; Treatment Outcome | 2021 |
Lysine analogue use during cancer surgery: a survey from a Canadian tertiary care centre.
Topics: Aminocaproic Acid; Blood Loss, Surgical; Humans; Lysine; Neoplasms; Ontario; Surveys and Questionnaires; Tertiary Care Centers; Tranexamic Acid | 2020 |
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Topics: Adenosine; Animals; Cell Hypoxia; Cell Line; Disease Progression; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidative Stress; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Transcriptome; Ubiquitination | 2021 |
Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinogenesis; Cell Line; Chromatin; CRISPR-Cas Systems; Cytarabine; Decitabine; Epigenesis, Genetic; Gene Editing; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Mesenchymal Stem Cells; Methylation; Mice; Mutation; Neoplasm Proteins; Neoplasms; Phenotype; Protein Isoforms; Protein Processing, Post-Translational; Repressor Proteins; Transcriptome | 2021 |
Development of an
Topics: Animals; Cell Line, Tumor; Fluorine Radioisotopes; GTP-Binding Proteins; Humans; Lysine; Mice; Neoplasms; Piperazines; Protein Glutamine gamma Glutamyltransferase 2; Transglutaminases | 2021 |
Detection of Tumor DNA in Human Plasma with a Functional PLL-Based Surface Layer and Plasmonic Biosensing.
Topics: DNA; Humans; Lysine; Neoplasms; Peptide Nucleic Acids; Surface Plasmon Resonance | 2021 |
Amino-Acid-Derived Naphthalenediimides as Versatile G-Quadruplex Binders.
Topics: Amino Acids; Base Sequence; Circular Dichroism; DNA; G-Quadruplexes; Humans; Imides; Ligands; Lysine; Naphthalenes; Neoplasms; Promoter Regions, Genetic; Solubility; Telomere; Thermodynamics; Up-Regulation; Water | 2017 |
Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness.
Topics: Acetylation; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Female; HEK293 Cells; HeLa Cells; Heme Oxygenase-1; Humans; Lysine; Mice, Inbred BALB C; Mice, Nude; Mutation; Neoplasm Invasiveness; Neoplasms; Transplantation, Heterologous; Tumor Burden | 2017 |
Lysines in the RNA Polymerase II C-Terminal Domain Contribute to TAF15 Fibril Recruitment.
Topics: Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Lysine; Magnetic Resonance Spectroscopy; Multiprotein Complexes; Mutation; Neoplasms; Promoter Regions, Genetic; Protein Binding; Protein Domains; RNA Polymerase II; TATA-Binding Protein Associated Factors; Transcription, Genetic; Translocation, Genetic | 2018 |
Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation.
Topics: Animals; Cell Line; Disease Progression; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysine; Mice; Models, Molecular; Mutation; Neoplasms; Phosphorylation; Protein Conformation; src-Family Kinases; Sumoylation | 2017 |
Dietary Compound Resveratrol Is a Pan-BET Bromodomain Inhibitor.
Topics: Acetylation; Antineoplastic Agents, Phytogenic; Cell Cycle Proteins; Diet; Epigenesis, Genetic; Gene Expression; Histones; Humans; Kinetics; Lysine; Molecular Docking Simulation; Neoplasms; Nuclear Proteins; Phytotherapy; Plant Extracts; Proteins; Resveratrol; Stilbenes; Transcription Factors | 2017 |
Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.
Topics: Animals; Cell Line; Cell Line, Tumor; Doxorubicin; Drug Carriers; HeLa Cells; Humans; Indicators and Reagents; Lysine; Maleimides; Mice; Mitoxantrone; Nanoparticles; Neoplasms; Pharmaceutical Preparations; Photosensitizing Agents; RAW 264.7 Cells; Tymovirus | 2017 |
KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase.
Topics: Acetyl Coenzyme A; Acyl Coenzyme A; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Crystallography, X-Ray; Female; Gene Expression Regulation; Histone Acetyltransferases; Histones; Humans; Ketoglutarate Dehydrogenase Complex; Lysine; Mice; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms; Protein Binding; Protein Domains; Transcription Initiation Site; Tyrosine | 2017 |
Coordinate regulation of stress signaling and epigenetic events by Acss2 and HIF-2 in cancer cells.
Topics: Acetate-CoA Ligase; Acetyl Coenzyme A; Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Epigenesis, Genetic; HEK293 Cells; Humans; Lysine; Mice; Mice, Nude; Neoplasms; Oxidative Stress; Real-Time Polymerase Chain Reaction; Signal Transduction | 2017 |
Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA, Neoplasm; Humans; Lysine; Naphthalimides; Neoplasms; Polyamines | 2018 |
Vesicles mimicking normal and cancer cell membranes exhibit differential responses to the cell-penetrating peptide Pep-1.
Topics: Amino Acid Sequence; Calorimetry, Differential Scanning; Cell Membrane; Cell-Penetrating Peptides; Cysteamine; Dose-Response Relationship, Drug; Liposomes; Lysine; Membrane Lipids; Microscopy, Electron, Scanning; Neoplasms; Peptides; Phosphates; Protein Structure, Secondary; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Thermogravimetry | 2018 |
Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.
Topics: Alternative Splicing; Cell Line, Tumor; Cluster Analysis; Exons; Gene Expression Regulation, Neoplastic; Gene Ontology; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Methyltransferases; Neoplasms; Nucleotide Motifs; Reproducibility of Results; RNA Splice Sites | 2018 |
Identification of a peptide inhibitor for the histone methyltransferase WHSC1.
Topics: Crystallography, X-Ray; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Neoplasms; Norleucine; Peptides; PR-SET Domains; Protein Conformation; Repressor Proteins | 2018 |
Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width.
Topics: Animals; Gene Expression Profiling; Genomics; HCT116 Cells; Histone Code; Histones; Humans; Liver; Lysine; Male; Methionine; Methylation; Mice, Inbred C57BL; Neoplasms | 2018 |
K63-linked polyubiquitin chains bind to DNA to facilitate DNA damage repair.
Topics: DNA; DNA Damage; DNA Repair; Humans; Lysine; Models, Molecular; Neoplasms; Polyubiquitin; Protein Processing, Post-Translational; Signal Transduction; Tumor Cells, Cultured; Ubiquitination | 2018 |
MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
Topics: Adaptor Proteins, Signal Transducing; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Chromatin; DNA Damage; DNA Methylation; DNA Repair; Genomic Instability; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Neoplasms; Nuclear Proteins; Trans-Activators; Tumor Cells, Cultured | 2018 |
Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2.
Topics: Circadian Rhythm; DNA, Complementary; HCT116 Cells; Humans; Lysine; Neoplasms; Period Circadian Proteins; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Ubiquitination | 2018 |
FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells.
Topics: Animals; F-Box Proteins; Female; HEK293 Cells; Humans; Interleukin-2; Lysine; Male; Melanoma, Experimental; Mice; Neoplasms; Programmed Cell Death 1 Receptor; Proteasome Endopeptidase Complex; T-Lymphocytes; Tumor Microenvironment; Ubiquitination | 2018 |
Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
Topics: Cell Line, Tumor; Demethylation; Enzyme Inhibitors; Histone Demethylases; Histones; Humans; Lysine; Methylation; Molecular Docking Simulation; Neoplasm Metastasis; Neoplasms; Structure-Activity Relationship | 2019 |
Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells
Topics: Animals; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Female; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histones; Humans; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Neoplastic Stem Cells; Peptide Fragments; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
The expanding landscape of 'oncohistone' mutations in human cancers.
Topics: Cell Transformation, Neoplastic; Histones; Humans; Lysine; Methylation; Mutation; Neoplasms; Nucleosomes; Protein Domains; Protein Processing, Post-Translational | 2019 |
A photo-triggered conjugation approach for attaching RGD ligands to biodegradable mesoporous silica nanoparticles for the tumor fluorescent imaging.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Survival; Endocytosis; Humans; Ligands; Light; Lysine; Mice; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Oligopeptides; Porosity; Silicon Dioxide; Tissue Distribution; Toxicity Tests, Acute | 2019 |
Fine-tuning AKT kinase activity through direct lysine methylation.
Topics: Animals; Carcinogenesis; Histone-Lysine N-Methyltransferase; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Methylation; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt | 2019 |
SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function.
Topics: CSK Tyrosine-Protein Kinase; Humans; Hydrogen Peroxide; Lysine; Molecular Chaperones; Neoplasms; Phosphorylation; Protein Binding; Protein Inhibitors of Activated STAT; Protein Processing, Post-Translational; Small Ubiquitin-Related Modifier Proteins; src-Family Kinases; SUMO-1 Protein; Sumoylation; Ubiquitin-Protein Ligases | 2019 |
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
Topics: A549 Cells; Animals; Doxycycline; Fluorescein-5-isothiocyanate; Folate Receptor 1; Folic Acid; HeLa Cells; Humans; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Molecular Targeted Therapy; Neoplasms; Oligopeptides; Polycystic Kidney Diseases; Protein Kinase C; Tissue Distribution; Trityl Compounds; Xenograft Model Antitumor Assays | 2019 |
MYC activity is negatively regulated by a C-terminal lysine cluster.
Topics: Animals; Cell Division; Gene Expression Regulation; Genes, myc; Heterografts; Humans; Lysine; Neoplasms; Phosphorylation; Protein Stability; Rats | 2014 |
Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression.
Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; COS Cells; Cysteine Endopeptidases; Endopeptidases; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Neoplasms; Protein Processing, Post-Translational; Repressor Proteins; RNA Polymerase III; Small Ubiquitin-Related Modifier Proteins; Transcription Factors; Transcription, Genetic | 2013 |
Enzymatic properties and anticancer activity of L-lysine α-oxidase from Trichoderma cf. aureoviride Rifai BKMF-4268D.
Topics: Amino Acid Oxidoreductases; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Stability; Female; Fungal Proteins; HT29 Cells; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; K562 Cells; Kinetics; Lysine; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Weight; Neoplasms; Protein Multimerization; Substrate Specificity; Time Factors; Trichoderma; Xenograft Model Antitumor Assays | 2013 |
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Epigenesis, Genetic; Histones; Humans; Hydrazones; Inhibitory Concentration 50; Isomerism; Jumonji Domain-Containing Histone Demethylases; Lysine; Methylation; Mice; Neoplasms; Small Molecule Libraries; Survival Analysis; Transcription, Genetic | 2013 |
Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Physical; Erythrocytes; Hot Temperature; Humans; Hydrogen-Ion Concentration; Lysine; Magnetics; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Oleic Acid; Paclitaxel; Polymers; Spectroscopy, Fourier Transform Infrared; Spectroscopy, Near-Infrared; Surface Properties; X-Ray Diffraction | 2013 |
Acetylation control of cancer cell metabolism.
Topics: Acetylation; Animals; Glycolysis; Humans; Lipogenesis; Lysine; Neoplasms; Pyruvate Kinase; Reactive Oxygen Species | 2014 |
An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Topics: Angiography; Animals; Contrast Media; Female; Gadolinium; Half-Life; Heterocyclic Compounds; Humans; Lysine; Magnetic Resonance Imaging; Mice; Mice, SCID; Neoplasms; Organometallic Compounds; Tissue Distribution | 2014 |
Lysine methylation promotes VEGFR-2 activation and angiogenesis.
Topics: Animals; Cell Line, Tumor; HEK293 Cells; Heterografts; Humans; Lysine; Methylation; Mice; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Protein Processing, Post-Translational; Vascular Endothelial Growth Factor Receptor-2; Zebrafish; Zebrafish Proteins | 2013 |
Protein corona on magnetite nanoparticles and internalization of nanoparticle-protein complexes into healthy and cancer cells.
Topics: Blood Proteins; Cell Culture Techniques; Cell Survival; Endocytosis; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Lysine; Magnetite Nanoparticles; Nanomedicine; Neoplasms; Particle Size; Surface Properties; Time Factors | 2014 |
Structure, functional characterization, and evolution of the dihydroorotase domain of human CAD.
Topics: Amino Acid Sequence; Aspartate Carbamoyltransferase; Bacterial Proteins; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Catalysis; Catalytic Domain; Cell Line; Dihydroorotase; DNA Repair; Escherichia coli; HEK293 Cells; Histidine; Humans; Hydrogen-Ion Concentration; Ions; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Neoplasms; Phosphorylation; Phylogeny; Protein Binding; Protein Multimerization; Sequence Homology, Amino Acid; Zinc | 2014 |
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Topics: Antioxidants; Ascorbic Acid; Dimerization; Gelatinases; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Lysine; Matrix Metalloproteinase 9; Neoplasms; Proline; Urokinase-Type Plasminogen Activator | 2014 |
Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.
Topics: Acetylation; Amino Acid Sequence; Base Sequence; Basic Helix-Loop-Helix Transcription Factors; Binding Sites; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Gene Knockdown Techniques; HCT116 Cells; HEK293 Cells; HeLa Cells; Hep G2 Cells; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lysine; Molecular Sequence Data; Neoplasms; RNA, Small Interfering; Sirtuin 1 | 2014 |
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Lysine; Male; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; Neoplasms; Phosphorylation; Pyruvate Dehydrogenase (Lipoamide); Pyruvate Dehydrogenase (Lipoamide)-Phosphatase; Sirtuin 3; Tyrosine | 2014 |
Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation?
Topics: Aged; BRCA2 Protein; Breast Neoplasms; Codon, Terminator; Female; Genetic Predisposition to Disease; Genotype; Germ-Line Mutation; Humans; Lysine; Male; Middle Aged; Neoplasms; Polymorphism, Genetic | 2014 |
Mechanisms of buffer therapy resistance.
Topics: Animals; Buffers; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Humans; Hydrogen-Ion Concentration; Lysine; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neoplasms | 2014 |
In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.
Topics: Asparagine; Binding Sites; Carrier Proteins; Chemistry, Pharmaceutical; Computational Biology; Crystallography, X-Ray; Drug Design; Humans; Hydrogen Bonding; Ligands; Lysine; Medicine, Chinese Traditional; Membrane Proteins; Mitosis; Molecular Dynamics Simulation; Neoplasms; Protein Conformation; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tryptophan | 2014 |
Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
Topics: Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Humans; Lysine; Mass Spectrometry; Neoplasms; Oligopeptides; Proteasome Endopeptidase Complex; Proteolysis; Proteomics; RNA Interference; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin; Ubiquitin Thiolesterase; Ubiquitin-Protein Ligases; Ubiquitin-Specific Peptidase 7 | 2014 |
SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells.
Topics: Acetylation; Blotting, Western; Cell Proliferation; Fluorescent Antibody Technique; Glucose; Glycolysis; Humans; Immunoprecipitation; Lactic Acid; Lysine; Neoplasms; Oxidation-Reduction; Oxidative Phosphorylation; Phenotype; Protein Processing, Post-Translational; Pyruvate Dehydrogenase (Lipoamide); Pyruvic Acid; Reactive Oxygen Species; Sirtuin 3; Tumor Cells, Cultured | 2014 |
iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
Topics: Animals; Antineoplastic Agents, Alkylating; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cyclophosphamide; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Humans; Lymphocyte Activation; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Lysine; Mice; Mice, Knockout; Myeloid Cells; Neoplasms; Nitric Oxide Synthase Type II; T-Lymphocytes, Regulatory; Transcription, Genetic; Transforming Growth Factor beta1; Tumor Burden | 2014 |
Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway.
Topics: Alleles; Amino Acid Sequence; Animals; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Extracellular Signal-Regulated MAP Kinases; Genes, ras; Humans; Lysine; MAP Kinase Signaling System; Mice; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase Kinases; Molecular Sequence Data; Neoplasms; raf Kinases; ras Proteins; Sequence Homology, Amino Acid; Tumor Suppressor Protein p53 | 2014 |
A pillararene-based ternary drug-delivery system with photocontrolled anticancer drug release.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chlorambucil; Drug Carriers; Drug Delivery Systems; Humans; Lysine; Magnetic Resonance Spectroscopy; Micelles; Nanocapsules; Neoplasms; Photochemistry; Prodrugs; Quaternary Ammonium Compounds; Reproducibility of Results; Solubility; Water | 2015 |
A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.
Topics: Alleles; Antineoplastic Agents; Cell Line; Cell Line, Tumor; DNA Mutational Analysis; Drug Resistance, Neoplasm; Gene Frequency; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms; Open Reading Frames; Polymorphism, Single Nucleotide; Prognosis; Protein Kinase Inhibitors; TOR Serine-Threonine Kinases; Ubiquitination | 2015 |
STAT3-driven transcription depends upon the dimethylation of K49 by EZH2.
Topics: Cell Line, Tumor; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Gene Expression; Gene Expression Regulation, Neoplastic; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Interleukin-6; Lysine; Mutation; Neoplasms; Phosphorylation; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Protein Processing, Post-Translational; Retroviridae; STAT3 Transcription Factor; Transcription, Genetic | 2015 |
Reversible lysine modification on proteins by using functionalized boronic acids.
Topics: Alkynes; Animals; Antineoplastic Agents, Phytogenic; Azides; Boronic Acids; Cell Line; Cell Line, Tumor; Folic Acid; Humans; Imines; Insulin; Lysine; Models, Molecular; Muramidase; Neoplasms; Paclitaxel; Polyethylene Glycols; Proteins | 2015 |
Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
Topics: Animals; Homeostasis; Humans; Lysine; Mice; Mice, Knockout; Mixed Function Oxygenases; Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Peptide Initiation Factors; Protein Biosynthesis; Protein Interaction Maps; Protein Processing, Post-Translational | 2015 |
MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Endoplasmic Reticulum-Associated Degradation; Endoribonucleases; Epithelial Cells; Humans; Intracellular Space; Lysine; Mice; Models, Biological; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteolysis; Proto-Oncogene Proteins c-met; Regulatory Factor X Transcription Factors; Signal Transduction; Transcription Factors; Ubiquitination; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; X-Box Binding Protein 1 | 2015 |
SUMOylation at K707 of DGCR8 controls direct function of primary microRNA.
Topics: Animals; Carcinogenesis; Cell Line; Cell Movement; Cells, Cultured; Humans; Lysine; Mice; Mice, Nude; MicroRNAs; Neoplasms; Phosphorylation; Protein Stability; RNA-Binding Proteins; SUMO-1 Protein; Sumoylation; Ubiquitination | 2015 |
Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations.
Topics: Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Methylation; Molecular Targeted Therapy; Mutation; Neoplasms; Polycomb Repressive Complex 2 | 2015 |
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.
Topics: Alleles; Anaplastic Lymphoma Kinase; Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histones; Humans; Introns; Isoenzymes; Lysine; Methylation; Mice; Molecular Sequence Data; Molecular Weight; Neoplasms; NIH 3T3 Cells; Oncogenes; Protein Structure, Tertiary; Receptor Protein-Tyrosine Kinases; RNA Polymerase II; RNA, Messenger; Signal Transduction; Transcription Initiation, Genetic | 2015 |
LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns.
Topics: Algorithms; Cell Line; Cell Line, Tumor; Cells, Cultured; Chromatin; Gene Expression Profiling; Gene Ontology; Gene Regulatory Networks; HeLa Cells; Hep G2 Cells; Histones; Humans; K562 Cells; Lysine; Methylation; Models, Genetic; Neoplasms; Promoter Regions, Genetic; RNA, Long Noncoding; RNA, Messenger; Transcription Initiation Site | 2015 |
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Neoplasms; Nuclear Proteins; Nucleotides; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleoside Diphosphate Reductase; RNA Interference; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Xenograft Model Antitumor Assays | 2015 |
ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.
Topics: Animals; Cell Proliferation; HCT116 Cells; HEK293 Cells; Humans; Lysine; Male; Mice, Nude; Neoplasms; Proteasome Endopeptidase Complex; Protein Binding; Proteolysis; Proto-Oncogene Proteins c-myc; Rats; Transcription, Genetic; Transcriptional Elongation Factors; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2016 |
Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Female; Humans; Hyaluronic Acid; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Pilot Projects; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2016 |
SCFFbl12 Increases p21Waf1/Cip1 Expression Level through Atypical Ubiquitin Chain Synthesis.
Topics: Autoantigens; Cyclin-Dependent Kinase Inhibitor p21; F-Box Proteins; Gene Expression Regulation, Neoplastic; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Lysine; Neoplasms; Proteasome Endopeptidase Complex; Protein Binding; Ubiquitination; Up-Regulation | 2016 |
The neuropilin-1 receptor mediates enhanced tumor delivery of H2K polyplexes.
Topics: Amino Acid Sequence; Animals; Antibodies; Cell Line, Tumor; Female; Genetic Therapy; Histidine; Humans; Luciferases; Lysine; Mice, Nude; Neoplasms; Neuropilin-1; Peptides; Transfection; Xenograft Model Antitumor Assays | 2016 |
Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cell Line; Cysteine; Drug Carriers; Female; Lysine; Maleimides; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasms; Serum Albumin, Bovine | 2016 |
The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.
Topics: Animals; Carcinogenesis; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; HeLa Cells; Histone Demethylases; Histones; Humans; Lysine; Mice; Neoplasms; NIH 3T3 Cells; Protein Binding; S Phase Cell Cycle Checkpoints | 2016 |
Optimizing Protonation States for Selective Double-Strand DNA Photocleavage in Hypoxic Tumors: pH-Gated Transitions of Lysine Dipeptides.
Topics: Acetylene; Dipeptides; DNA; Humans; Hydrogen-Ion Concentration; Light; Lysine; Neoplasms; Photolysis; Photosensitizing Agents; Protons | 2016 |
A New Chromatin-Cytoskeleton Link in Cancer.
Topics: Chromatin; Cytoskeleton; Genomic Instability; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Tubulin | 2016 |
SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
Topics: Cell Membrane; Enzyme Activation; Gene Expression; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Neoplasms; Phosphorylation; Pleckstrin Homology Domains; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine | 2016 |
Alteration of histone H3 lysine 9 dimethylation in peripheral white blood cells of septic patients with trauma and cancer.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Female; Fluorescent Antibody Technique; Histones; Humans; Leukocytes; Lysine; Male; Methylation; Middle Aged; Neoplasms; ROC Curve; Sepsis; Wounds and Injuries | 2016 |
Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Cloning, Molecular; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genome, Human; HEK293 Cells; HeLa Cells; Hep G2 Cells; HT29 Cells; Humans; Lysine; MCF-7 Cells; Neoplasms; Nuclear Proteins; Plasmids; Protein Domains; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Transcription Factors; Transcriptional Activation | 2016 |
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
Topics: beta-Transducin Repeat-Containing Proteins; Breast Neoplasms; Cell Line, Tumor; Chromatin Assembly and Disassembly; DNA Helicases; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genes, Essential; Glycogen Synthase Kinase 3 beta; Histones; Humans; Lysine; Male; Methylation; Molecular Targeted Therapy; Neoplasms; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; PTEN Phosphohydrolase; Tumor Necrosis Factor-alpha; Ubiquitination | 2017 |
Intragenic DNA methylation prevents spurious transcription initiation.
Topics: Animals; Cell Line; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Genes; Histone-Lysine N-Methyltransferase; Histones; Lysine; Mice; Mouse Embryonic Stem Cells; Neoplasms; Polyadenylation; Ribosomes; RNA Caps; RNA Polymerase II; RNA Stability; RNA, Messenger; Transcription Initiation Site; Transcription Initiation, Genetic | 2017 |
Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Chromatin; Chromatin Immunoprecipitation; Fluorescent Antibody Technique; Histone Deacetylases; Histones; Humans; Lysine; Methylation; Mice; Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors for Activated C Kinase; Receptors, Cell Surface; Response Elements; RNA Polymerase II; Time Factors; Tretinoin; Tumor Suppressor Proteins; YY1 Transcription Factor | 2017 |
Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.
Topics: Apoptosis; Crystallography, X-Ray; DNA Repair; Histones; Humans; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Lysine; Methylation; Models, Molecular; Molecular Sequence Data; Mutation; Neoplasms; Nuclear Proteins; Peptides; Protein Array Analysis; Protein Binding; Protein Structure, Tertiary; Tumor Suppressor Proteins | 2008 |
Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain.
Topics: 3T3 Cells; Animals; Cattle; Cell Membrane; Cell Survival; Glutamic Acid; Humans; Kinetics; Lysine; Mice; Microscopy, Fluorescence; Mutation; Neoplasms; Oncogenes; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Substrate Specificity | 2008 |
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
Topics: 3' Untranslated Regions; Algorithms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Lysine; Male; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasms; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Stomach Neoplasms; Transcription Factors | 2008 |
Effects of L-arginine and L-lysine mixtures on splenic sympathetic nerve activity and tumor proliferation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Carcinoma; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Female; Humans; Immune Tolerance; Immunologic Factors; Killer Cells, Natural; Lysine; Male; Mice; Mice, Inbred BALB C; Neoplasms; Neuroimmunomodulation; Rats; Rats, Wistar; Spleen; Sympathetic Nervous System; Treatment Outcome | 2009 |
PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Mammary Neoplasms, Animal; Methylation; Mice; Mice, Knockout; Neoplasms; Nuclear Receptor Coactivators; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-fos; ras Proteins; Serum Response Factor | 2009 |
Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers.
Topics: Acetylation; Binding Sites; Blotting, Western; Breast Neoplasms; Catalysis; Catalytic Domain; Cell Line; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Female; Histone Acetyltransferases; Histones; Humans; Immunohistochemistry; Kidney Neoplasms; Lysine; Male; Neoplasms; Nucleosomes; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Recombinant Proteins; Tissue Array Analysis; Urinary Bladder Neoplasms | 2009 |
A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.
Topics: Binding Sites; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; Epidermal Growth Factor; Humans; Kaempferols; Kinetics; Lysine; Neoplasms; Phosphorylation; Protein Kinases; Recombinant Proteins; Reference Values; Ribosomal Protein S6 Kinases, 90-kDa; Skin; Tetradecanoylphorbol Acetate; Tissue Array Analysis; Valine | 2009 |
Constructing bioactive peptides with pH-dependent activities.
Topics: Amino Acid Sequence; Animals; Arginine; Cell Death; Cell Line; Fluoresceins; Histidine; Humans; Hydrogen-Ion Concentration; Lysine; Mice; Mice, Nude; Micelles; Neoplasms; Peptides; Structure-Activity Relationship; Transplantation, Homologous | 2009 |
C-lysine conjugates: pH-controlled light-activated reagents for efficient double-stranded DNA cleavage with implications for cancer therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; DNA Cleavage; Humans; Hydrogen-Ion Concentration; Light; Lysine; Models, Molecular; Molecular Structure; Neoplasms; Photolysis; Plasmids | 2009 |
The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.
Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; Checkpoint Kinase 1; DNA Damage; DNA Replication; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Lysine; Neoplasms; Phosphorylation; Protein Kinases; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; RNA Interference; SKP Cullin F-Box Protein Ligases; Stress, Physiological; Time Factors; Ubiquitination | 2009 |
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line; Cell Line, Tumor; Cell Survival; DNA Damage; Docetaxel; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Half-Life; Humans; Lysine; Mice; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Nitrophenols; Phosphorylation; Piperazines; Polyubiquitin; Prognosis; Protein Binding; Protein Stability; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Sulfonamides; Taxoids; Ubiquitin Thiolesterase; Ubiquitination; Ultraviolet Rays; Xenograft Model Antitumor Assays | 2010 |
[Biosynthesis of L-lysine-alpha-oxidase, an antitumor enzyme, by Trichoderma spp].
Topics: Amino Acid Oxidoreductases; Animals; Antineoplastic Agents; Brevibacterium; Fungal Proteins; Humans; Lysine; Neoplasms; Trichoderma | 2009 |
G9a and Glp methylate lysine 373 in the tumor suppressor p53.
Topics: Autoantigens; DNA Damage; DNA Methylation; Gene Expression Regulation; Golgi Matrix Proteins; Histocompatibility Antigens; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Neoplasms; Peptides; Protein Processing, Post-Translational; Proteins; Recombinant Proteins; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2010 |
Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
Topics: Acetylation; Animals; Cell Death; Cell Line, Tumor; DNA Damage; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lysine; Male; Neoplasms; Sirtuin 1; Topoisomerase II Inhibitors; Valproic Acid | 2010 |
The H3K27me3 demethylase dUTX is a suppressor of Notch- and Rb-dependent tumors in Drosophila.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Calcium-Binding Proteins; Cell Cycle; Drosophila melanogaster; Drosophila Proteins; Histones; Humans; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Lysine; Membrane Proteins; Mutation; Neoplasms; Oxidoreductases, N-Demethylating; Phenotype; Photoreceptor Cells, Invertebrate; Pigmentation; Receptors, Notch; Recombinant Fusion Proteins; RNA Interference; Serrate-Jagged Proteins | 2010 |
Chromatin protein L3MBTL1 is dispensable for development and tumor suppression in mice.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brain; Cell Cycle; Chromatin; Cyclin E; Gene Expression Regulation; Gene Knockout Techniques; Growth and Development; HeLa Cells; Histones; Humans; Longevity; Lymphopoiesis; Lysine; Male; Methylation; Mice; Molecular Sequence Data; Neoplasms; Nuclear Proteins; Repressor Proteins; Survival Rate; Tumor Suppressor Proteins | 2010 |
Negative regulation of hypoxic responses via induced Reptin methylation.
Topics: Animals; ATPases Associated with Diverse Cellular Activities; Carrier Proteins; Cell Hypoxia; Cell Line; DNA Helicases; Female; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysine; Methylation; Mice; Models, Biological; Neoplasms; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Protein Binding; Xenograft Model Antitumor Assays | 2010 |
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Ascorbic Acid; Camellia sinensis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Micronutrients; Neoplasm Invasiveness; Neoplasms; Plant Extracts; Proline; Protease Inhibitors; Tetradecanoylphorbol Acetate | 2010 |
Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cations; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Feasibility Studies; Gene Transfer Techniques; Humans; Lysine; Neoplasms; Paclitaxel; Polymers; RNA, Small Interfering | 2010 |
Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Topics: Adenosine Triphosphatases; Amino Acid Sequence; Animals; ATPases Associated with Diverse Cellular Activities; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin; DNA-Binding Proteins; E2F Transcription Factors; Epigenesis, Genetic; Genes, Reporter; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Protein Isoforms; RNA, Small Interfering; Sequence Alignment; Transcriptional Activation | 2010 |
Lysine methylation of promoter-bound transcription factors and relevance to cancer.
Topics: DNA; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Neoplasms; NF-kappa B; Promoter Regions, Genetic; STAT3 Transcription Factor | 2011 |
Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation.
Topics: Cell Differentiation; Cellular Senescence; Gene Expression Regulation; Genome, Human; Histone Demethylases; Histones; Homeodomain Proteins; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Neoplasms; Nuclear Proteins; Transcription, Genetic | 2010 |
Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.
Topics: Cell Survival; Endopeptidases; HEK293 Cells; HeLa Cells; Histone Deacetylases; Humans; Lysine; Neoplasm Proteins; Neoplasms; Repressor Proteins; Sin3 Histone Deacetylase and Corepressor Complex; Ubiquitination | 2011 |
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Dendrimers; Doxorubicin; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Lysine; Male; Neoplasms; Polyethylene Glycols; Polylysine; Rats; Rats, Sprague-Dawley | 2011 |
Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex.
Topics: Animals; Arginine; beta-Galactosidase; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Therapy; Humans; Leucine; Lysine; Mice; Mice, Inbred BALB C; Neoplasms; Polyethyleneimine | 2011 |
Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex.
Topics: Animals; Arginine; Female; Gene Expression; Humans; Leucine; Lysine; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Neoplasms; Polypropylenes | 2011 |
siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Down-Regulation; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Lysine; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Polyethyleneimine; Polymers; RNA, Small Interfering; Stearic Acids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
And-1 is required for the stability of histone acetyltransferase Gcn5.
Topics: Acetylation; Cell Cycle; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; DNA-Binding Proteins; HCT116 Cells; HEK293 Cells; HeLa Cells; Histones; Humans; Immunoblotting; Lysine; Neoplasms; p300-CBP Transcription Factors; Protein Binding; Protein Stability; RNA Interference | 2012 |
Differences in DNA condensation and release by lysine and arginine homopeptides govern their DNA delivery efficiencies.
Topics: Animals; Arginine; Biological Transport; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; DNA Packaging; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Gene Transfer Techniques; Genetic Vectors; Humans; Lysine; Molecular Weight; Neoplasms; Nucleic Acid Conformation; Oligopeptides; Particle Size; Peptides; Structure-Activity Relationship | 2011 |
The ubiquitin clan: A protein family essential for life.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Lysine; Neoplasms; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Ubiquitin; Ubiquitination | 2011 |
Structure of human SMYD2 protein reveals the basis of p53 tumor suppressor methylation.
Topics: Calorimetry; Cell Line, Tumor; Crystallography, X-Ray; Genes, Tumor Suppressor; Histone-Lysine N-Methyltransferase; Histones; Humans; Kinetics; Lysine; Methylation; Molecular Conformation; Neoplasms; Protein Binding; Transcription, Genetic; Tumor Suppressor Protein p53 | 2011 |
Arginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase.
Topics: Amphibian Proteins; Animals; Antineoplastic Agents; Arginine; Humans; K562 Cells; Lysine; Models, Molecular; Neoplasms; Rana pipiens; Ribonucleases | 2011 |
Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells.
Topics: Acetylation; Antigens, Nuclear; bcl-2-Associated X Protein; Cell Death; Cell Line, Tumor; Cytoplasm; DNA-Binding Proteins; HEK293 Cells; HeLa Cells; Humans; Ku Autoantigen; Lysine; Neoplasms; Protein Binding; Protein Transport; Serpins | 2012 |
Histone deacetylase inhibitors in the therapy of cancer: much to learn.
Topics: Cell Death; Cell Movement; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Lysine; Neoplasms | 2010 |
RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility.
Topics: Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Dissociation Inhibitors; Humans; Lysine; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; rho GTP-Binding Proteins; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Sumoylation; Wound Healing; X-Linked Inhibitor of Apoptosis Protein | 2012 |
A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Topics: Amines; Animals; Cell Death; Cell Line, Tumor; Chromatography, Gel; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Flow Cytometry; Gene Transfer Techniques; Humans; Hydroxylation; Lysine; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Particle Size; Polyesters; Polyethylene Glycols; Polylysine; Polymerization; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared | 2012 |
Inhibition of NAMPT pathway by FK866 activates the function of p53 in HEK293T cells.
Topics: Acetylation; Acrylamides; Apoptosis; Cell Cycle; Cytokines; Enzyme Inhibitors; Gene Knockdown Techniques; HEK293 Cells; Humans; Lysine; Metabolic Networks and Pathways; Neoplasms; Nicotinamide Phosphoribosyltransferase; Piperidines; Simian virus 40; Sirtuin 1; Tumor Suppressor Protein p53 | 2012 |
Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells.
Topics: Aging; Animals; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Colitis; Colon; Death-Associated Protein Kinases; Dextran Sulfate; Epithelial Cells; Gene Expression; Histones; Intestinal Mucosa; Lysine; Male; Methylation; Mice; Mice, Inbred BALB C; Neoplasms | 2012 |
Oncogene Ras/phosphatidylinositol 3-kinase signaling targets histone H3 acetylation at lysine 56.
Topics: Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Gene Expression Regulation, Neoplastic; HeLa Cells; Histones; Humans; Lysine; Neoplasms; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases; ras Proteins; RNA, Small Interfering; Signal Transduction | 2012 |
Chd5 requires PHD-mediated histone 3 binding for tumor suppression.
Topics: Amino Acid Sequence; Animals; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; DNA Helicases; Genetic Loci; Genome; Histones; Homeodomain Proteins; Humans; Lysine; Methylation; Mice; Models, Molecular; Molecular Sequence Data; Mutation; Neoplasms; Neuroblastoma; Peptides; Protein Binding; Structure-Activity Relationship | 2013 |
Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition.
Topics: Animals; Cell Line, Tumor; Female; Gene Expression; Gene Silencing; Histidine; Humans; Lysine; Mice; Nanostructures; Neoplasms; Proto-Oncogene Proteins c-raf; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2013 |
Malignant tumor disease as a sub-chronic, progressive intoxication on the basis of the perpetuation of the release of amino acids, initiated by a retrograde-differentiated muscle degradation protease.
Topics: Amino Acids; Animals; Cell Differentiation; Cell Transformation, Neoplastic; Disease Progression; Endopeptidases; Humans; Lysine; Models, Biological; Muscle Proteins; Muscle, Skeletal; Neoplasm Proteins; Neoplasms; Nutrition Disorders | 2002 |
Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Topics: Acetylation; Cadherins; Chromatin; Chromosomal Proteins, Non-Histone; CpG Islands; DNA Methylation; DNA-Binding Proteins; Gene Silencing; Histones; Humans; Lysine; Methyl-CpG-Binding Protein 2; Methylation; Neoplasms; Promoter Regions, Genetic; Protein Binding; Repressor Proteins; Tumor Cells, Cultured | 2002 |
8-Hydroxylysine: an inhibitor of glutamine and protein synthesis by the Ehrlich ascites carcinoma cell.
Topics: Ascites; Glutamine; Hydroxylysine; Lysine; Neoplasms; Protein Biosynthesis; Proteins | 1957 |
Labeling of histones and other nuclear proteins with L-lysine-U-C14 in tissues of tumor-bearing rats.
Topics: Animals; Encephalomyelitis; Histones; Lysine; Neoplasms; Nuclear Proteins; Nucleoproteins; Rats | 1958 |
Labeling of nuclear proteins of tumors and other tissues in vitro with L-lysine-U-C14 and L-alanine-U-C14.
Topics: Alanine; Biochemical Phenomena; Humans; In Vitro Techniques; Lysine; Neoplasms; Nuclear Proteins; Nucleoproteins | 1960 |
The effect of hydroxylysine on ascites cell growth in vitro.
Topics: Ascites; Cell Cycle; Cell Proliferation; Hydroxylysine; In Vitro Techniques; Lysine; Neoplasms; Neoplasms, Experimental | 1963 |
The isolation of intermediary metabolites of L-lysine-U-C14 from tissues of tumor-bearing rats.
Topics: Animals; Lysine; Neoplasms; Neoplasms, Experimental; Rats | 1963 |
ANALYSIS OF PEPTIDES OF THE MOCERATELY LYSINE RICH HISTONE FRACTION, F2B, OF THE WALKER TUMOR AND OTHER TISSUES.
Topics: Animals; Carcinoma 256, Walker; Chromatography; Electrophoresis; Histones; Lysine; Neoplasm Proteins; Neoplasms; Peptides; Research | 1963 |
BIOCHEMISTRY OF HISTONES AND THE CELL CYCLE.
Topics: Animals; Carbon Isotopes; Carcinoma 256, Walker; Cell Division; Cell Nucleus; Chromatography; DNA; DNA, Neoplasm; Electrophoresis; Histones; Lysine; Neoplasm Proteins; Neoplasms; Research | 1963 |
STUDIES ON ACIDIC NUCLEAR PROTEINS OF THE WALKER TUMOR AND LIVER.
Topics: Amino Acids; Animals; Carbon Isotopes; Carcinoma 256, Walker; DNA; DNA, Neoplasm; Liver; Lysine; Neoplasms; Neoplasms, Experimental; Nuclear Proteins; Nucleoproteins; Proteins; Rats; Research; RNA; RNA, Neoplasm | 1963 |
[CONTRIBUTION TO THE STUDY OF RIBONUCLEOPROTEINS OF NORMAL AND NEOPLASTIC TISSUES].
Topics: Alanine; Arginine; Aspartic Acid; Chemical Phenomena; Chemistry; Glutamates; Glycine; Isoleucine; Leucine; Liver; Lysine; Mice; Neoplasm Proteins; Neoplasms; Nucleoproteins; Phenylalanine; Rats; Research; Ribonucleoproteins; RNA; RNA, Neoplasm; Serine; Threonine; Tyrosine; Valine | 1963 |
A TRANSPORT SYSTEM SERVING FOR MONO- AND DIAMINO ACIDS.
Topics: Amino Acids; Aminobutyrates; Aminoisobutyric Acids; Arginine; Asparagine; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Glutamine; Glycine; Leucine; Lysine; Neoplasms; Ornithine; Phenylalanine; Proteins; Research | 1964 |
INCORPORATION OF 8-AZAGUANINE AND GROWTH INHIBITION IN MAMMALIAN SPINNER CULTURES.
Topics: Azaguanine; Carbon Isotopes; Cell Biology; DNA; DNA, Neoplasm; Guanine; Lysine; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Pharmacology; Proteins; Research; RNA; RNA, Neoplasm; Tissue Culture Techniques; Urethane | 1964 |
AN EXPERIMENTAL STUDY OF TISSUE-CONCENTRATION RATIOS OF AS74 ARSENATE AND LABELED ORGANIC CONJUGATES.
Topics: Animals; Arsenates; Arsenic; Arsenicals; Azo Compounds; Brain Neoplasms; Ependymoma; Lysine; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Radioisotopes; Radionuclide Imaging; Research | 1964 |
[DIAGNOSTIC VALUE OF TOLBUTAMIDE AND 1-LYSINE IN INSULAR ADENOMA OF THE PANCREAS].
Topics: Adenoma, Islet Cell; Humans; Hyperinsulinism; Hypoglycemia; Lysine; Neoplasms; Pancreatic Neoplasms; Pharmacology; Tolbutamide | 1964 |
EXPERIMENTAL AND CLINICAL EVALUATION OF ARGINASE INHIBITOR IN CHRONIC URINARY OBSTRUCTION.
Topics: Arginase; Biomedical Research; Dogs; Enzyme Inhibitors; Humans; Lysine; Male; Neoplasms; Preoperative Care; Prostatic Hyperplasia; Prostatic Neoplasms; Research; Uremia; Urethral Stricture; Urinary Bladder Neck Obstruction; Urologic Diseases | 1965 |
THE UPTAKE OF DIFFERENTIALLY COUPLED 74-AS-ARSANO-POLY-L-LYSINE IN TUMOR-BEARING MOUSE TISSUES.
Topics: Animals; Arsenicals; Blood; Dialysis; Kidney; Liver; Lysine; Mice; Neoplasms; Neoplasms, Experimental; Radioisotopes; Radionuclide Imaging; Renal Dialysis; Research | 1964 |
Antibiotic activity of Leu-Lys rich model peptides.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Erythrocytes; Fungi; Hemolysis; Humans; Leucine; Lysine; Microbial Sensitivity Tests; Neoplasms; Peptide Fragments | 2003 |
Formation of acrolein-derived 2'-deoxyadenosine adduct in an iron-induced carcinogenesis model.
Topics: Acrolein; Aldehydes; Animals; Antibodies, Monoclonal; Binding, Competitive; Cattle; Cell Nucleus; Deoxyadenosines; DNA Adducts; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Ions; Iron; Lipid Peroxidation; Liver; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Chemical; Neoplasms; Oxidative Stress; Oxygen; Peroxidase; Rats; Rats, Wistar; Threonine; Thymus Gland; Time Factors | 2003 |
Three dimensional analysis of histone methylation patterns in normal and tumor cell nuclei.
Topics: Cell Line, Tumor; Cell Nucleus; Centromere; DNA; Female; Fibroblasts; Heterochromatin; Histones; Humans; Lysine; Methylation; Monocytes; Neoplasms; T-Lymphocytes | 2004 |
Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
Topics: Actins; Anaphase-Promoting Complex-Cyclosome; Antibodies, Monoclonal; Basic Helix-Loop-Helix Transcription Factors; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Glutathione Transferase; Humans; Hydroxylation; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leucine; Lysine; Models, Molecular; Mutation; Mutation, Missense; Neoplasms; Peptides; Plasmids; Proline; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Serine; Time Factors; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin; Ubiquitin-Protein Ligase Complexes; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.
Topics: Acetylation; CpG Islands; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Lymphocytes; Lysine; Neoplasms; Promoter Regions, Genetic; Protein Processing, Post-Translational; Repetitive Sequences, Nucleic Acid; Tumor Cells, Cultured | 2005 |
Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.
Topics: Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Glycolysis; Humans; Lysine; Neoplasm Proteins; Neoplasms; Pyruvaldehyde | 2005 |
Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate.
Topics: Animals; Bone Marrow; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dimerization; Electrophoresis, Polyacrylamide Gel; Fibronectins; Humans; Immunoconjugates; Immunoglobulin Fragments; Immunoglobulin G; Lysine; Mice; Neoplasms; Pentetic Acid; Protein Structure, Tertiary; Radioimmunotherapy; Radiometry; Time Factors | 2005 |
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.
Topics: Base Sequence; Cell Line; Cell Line, Tumor; Eukaryotic Translation Initiation Factor 5A; Humans; Lysine; Molecular Sequence Data; Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Peptide Initiation Factors; Polyadenylation; Polyribosomes; Protein Biosynthesis; Protein Isoforms; Protein Precursors; Protein Processing, Post-Translational; RNA-Binding Proteins; RNA, Messenger; Transfection | 2006 |
PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice.
Topics: Animals; Dendrimers; Drug Carriers; Injections, Intravenous; Liver; Lysine; Male; Mice; Mice, Inbred Strains; Neoplasms; Polyethylene Glycols; Spleen; Tissue Distribution | 2006 |
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Topics: Amifostine; Animals; Body Weight; Creatinine; Kidney; Lysine; Male; Neoplasms; Octreotide; Organometallic Compounds; Proteinuria; Radiation Injuries; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Tomography, Emission-Computed, Single-Photon | 2007 |
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.
Topics: Caco-2 Cells; Carrier Proteins; Cells, Cultured; Colonic Neoplasms; CpG Islands; DNA Methylation; Epigenesis, Genetic; Histones; Humans; Lysine; Methylation; Methyltransferases; Neoplasms; Viral Envelope Proteins | 2007 |
Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
Topics: Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Histones; Homeodomain Proteins; Humans; Lysine; Methylation; Myeloid Ecotropic Viral Integration Site 1 Protein; Neoplasm Proteins; Neoplasms; Otx Transcription Factors; Transcription, Genetic | 2008 |
The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
Topics: Amino Acid Sequence; Binding Sites; Cell Line; Crystallography, X-Ray; Deubiquitinating Enzyme CYLD; Genes, Tumor Suppressor; Humans; JNK Mitogen-Activated Protein Kinases; Lysine; Models, Molecular; Molecular Sequence Data; Mutation; Neoplasms; NF-kappa B; Polyubiquitin; Protein Structure, Tertiary; Recombinant Fusion Proteins; Sequence Alignment; Signal Transduction; Substrate Specificity; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Ubiquitin-Specific Peptidase 7; Zinc | 2008 |
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; DNA Mutational Analysis; Female; Glutamic Acid; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Lysine; Male; Middle Aged; Mutation; Neoplasms; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins c-akt; Stomach Neoplasms | 2008 |
[Multiple post-translational modifications implied in the gene expression regulation: example of the sumoylation of Ets factors].
Topics: Acetylation; Animals; Disease Models, Animal; Gene Expression Regulation; Humans; Leukemia; Lysine; Mice; Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Protein c-ets-1; SUMO-1 Protein; Ubiquitin | 2007 |
Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.
Topics: Cell Line, Tumor; Centrosome; Chromosomal Instability; Cyclin-Dependent Kinase Inhibitor p16; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methyltransferases; Neoplasms; Protein Methyltransferases; Repressor Proteins; Telomere; Tumor Suppressor Proteins | 2008 |
Aminoaciduria resulting from cycloleucine administration in man.
Topics: Amino Acids; Arginine; Cystinuria; Humans; Kidney Tubules; Lysine; Neoplasms; Ornithine | 1967 |
Small intrathecal doses of lysine-acetylsalicylate relieve intractable pain in man.
Topics: Analgesics; Aspirin; Back Pain; Drug Evaluation; Humans; Injections, Spinal; Lysine; Neoplasms; Pain, Intractable | 1983 |
The living state and cancer.
Topics: Aldehydes; Ascorbic Acid; Biological Evolution; Chemical Phenomena; Chemistry; Electric Conductivity; Electron Spin Resonance Spectroscopy; Electron Transport; Ethylenediamines; Glutathione; Lysine; Methylamines; Mixed Function Oxygenases; Neoplasms; Origin of Life; Oxygen; Proteins; Pyruvaldehyde | 1980 |
Apparent methionine auxotrophy of some tumour cell lines may be linked to impaired amino acid transport.
Topics: Animals; Biological Transport; Carcinoma 256, Walker; Cell Division; Cell Line; Embryo, Mammalian; Fibroblasts; Humans; Leukemia, Experimental; Lysine; Methionine; Mice; Neoplasms; Rats; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Researchers develop ceramic drug delivery system.
Topics: Acquired Immunodeficiency Syndrome; Animals; Calcium Phosphates; Drug Implants; Humans; Lysine; Neoplasms; Osteoporosis | 1995 |
Cyclooxygenase inhibitors prevent the induction of tolerance to the toxic effects of tumor necrosis factor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Combined Modality Therapy; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunotherapy; Indomethacin; Lysine; Mice; Mice, Inbred C57BL; Neoplasms; Piroxicam; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1993 |
Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.
Topics: Animals; Antibodies, Monoclonal; Female; Glycolates; Hydrogen-Ion Concentration; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Kidney; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Mertiatide; Tissue Distribution | 2002 |
Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells.
Topics: Base Sequence; Cell Division; Humans; Lysine; Mutation; Neoplasms; Nuclear Proteins; Oncogene Proteins, Viral; Papillomaviridae; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
[Analgesic action of lysine acetylsalicylate in intravenous administration on pain caused by cancer].
Topics: Aspirin; Humans; Lysine; Neoplasms; Pain, Intractable; Palliative Care | 1975 |
Differences in uptake of aminoacids by patients with various forms of cancer.
Topics: Amino Acids; Female; Humans; Lysine; Male; Neoplasm Metastasis; Neoplasms; Valine | 1978 |
[A new method for the detection of sensitized lymphocytes in malignant diseases--PAL test].
Topics: Hemagglutination Tests; Humans; Lymphocytes; Lysine; Neoplasms; Oligopeptides | 1978 |
Diagnostic meaning of the urinary output of Nepsilon-methylated lysines. Investigation of healthy individuals and patients with malignant diseases, myopathies or renal failure.
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Female; Humans; Infant; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Muscular Diseases; Neoplasms; Tritium | 1975 |
Heterogeneity of heat response in murine, canine and human tumors: influence on predictive assays.
Topics: Animals; Cell Survival; Dogs; Humans; Hyperthermia, Induced; Lysine; Mice; Neoplasms; Neoplasms, Experimental; Temperature; Thermodynamics; Thermography | 1991 |
Recovery of low thymic hormone levels in cancer patients by lysine-arginine combination.
Topics: Adult; Aged; Arginine; Drug Combinations; Female; Humans; Lysine; Male; Middle Aged; Neoplasms; T-Lymphocytes; Thymic Factor, Circulating; Thymus Hormones | 1990 |
A predictive assay for human tumor cellular response to hyperthermia using dansyl lysine staining and flow cytometry.
Topics: Biopsy; Cell Survival; Flow Cytometry; Fluorescence; Humans; Hyperthermia, Induced; Lysine; Neoplasms; Staining and Labeling | 1988 |
[Chronic refractory pain in cancer patients. Value of the spinal injection of lysine acetylsalicylate. 60 cases].
Topics: Adult; Aged; Analgesics; Aspirin; Chronic Disease; Female; Humans; Injections, Spinal; Lysine; Male; Middle Aged; Neoplasms; Pain | 1987 |
[Analgesia with an implanted device for repetitive intrathecal injections of morphine].
Topics: Adolescent; Adult; Aged; Aspirin; Chronic Disease; Clonidine; Drug Tolerance; Humans; Injections, Spinal; Lysine; Middle Aged; Morphine; Neoplasms; Pain; Receptors, Opioid | 1985 |
H1(0) histones of normal and cancer human cells. Amino acid composition of H1 purified by polyacrylamide gel electrophoresis.
Topics: Amino Acids; Arginine; Carcinoma, Hepatocellular; Cell Line; Histones; Humans; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Lysine; Neoplasms | 1986 |
Fasting plasma amino acid levels in cancer patients.
Topics: Adolescent; Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Esophageal Neoplasms; Fasting; Female; Humans; Lysine; Male; Middle Aged; Neoplasms; Tyrosine | 1985 |
[Comparative study of the analgesic activity of 1 g injectable Aspegic and injectable Noramidopyrine].
Topics: Adult; Aged; Aminopyrine; Analgesics; Aspirin; Dipyrone; Female; Humans; Lysine; Male; Middle Aged; Neoplasms; Pain, Postoperative; Pyrazolones; Surgery, Plastic | 1985 |
Fibrinogen and metastases.
Topics: Animals; Cell Line; Culture Media; Female; Fibrinogen; gamma-Glutamyltransferase; Humans; In Vitro Techniques; Lysine; Mitochondria; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Oxygen Consumption; Plasmacytoma; Pregnancy; Thrombin; Thrombosis; Wound Healing | 1974 |
Learning and memory in the immune response.
Topics: Animals; Antibody Formation; Antigen-Antibody Reactions; Dinitrophenols; gamma-Globulins; Lysine; Neoplasms; Rabbits | 1966 |
Beta2-microglobulin: occurrence in fetal life and malignancy.
Topics: Aging; Carbon Radioisotopes; Female; Fetal Proteins; Fetus; Gestational Age; Humans; Immunodiffusion; Infant, Newborn; Infant, Premature; Isoleucine; Leukemia; Lysine; Maternal-Fetal Exchange; Neoplasms; Pregnancy; Serum Globulins; Umbilical Cord | 1974 |
Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption.
Topics: Animals; Ascitic Fluid; Calcium; Cell Adhesion; Chromium Isotopes; Hemadsorption; Immunity, Cellular; Immunologic Techniques; Leukemia, Experimental; Lymphocytes; Lysine; Magnesium; Male; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Neoplasms | 1973 |
Comparative high-resolution electrophoresis of tumor histones: variation in phosphorylation as a function of cell replication rate.
Topics: Alkaline Phosphatase; Animals; Densitometry; Electrophoresis, Disc; Histones; Lysine; Methods; Mice; Mice, Inbred Strains; Mitosis; Neoplasms; Neoplasms, Experimental; Phosphoric Acids; Rats; Rats, Inbred Strains; Time Factors | 1972 |
Immunosuppressive effects of L-asparaginase.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Alanine; Antibody Formation; Antigens; Asparaginase; Asparagine; Breast Neoplasms; Carcinoma; Child, Preschool; Female; Glutamates; Hemocyanins; Humans; Hypersensitivity, Delayed; Immunoglobulins; Immunosuppressive Agents; Lectins; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphocytes; Lysine; Male; Middle Aged; Neoplasms; Osteosarcoma; Tyrosine | 1970 |
Occurrence of L-lysine dehydrogenase (LyDH) in human serum in normal and some pathological states.
Topics: Adolescent; Adult; Amino Acid Oxidoreductases; Breast Neoplasms; Female; Heart Diseases; Heart Failure; Humans; Kidney Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Lysine; Male; Middle Aged; Multiple Myeloma; Myocardial Infarction; Neoplasms; Prostatic Neoplasms; Urogenital Neoplasms | 1967 |
[Use of L-103 hydrolysin in malignant tumors].
Topics: Amino Acids; Humans; Neoplasms; Protein Hydrolysates | 1959 |
[CLINICAL USE OF HYDROLYSIN L-103].
Topics: Anaphylaxis; Burns; Humans; Neoplasms; Peptic Ulcer; Protein Hydrolysates | 1963 |